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Introduction and aims of the study 
How it all started! 
A microscopical vasovasostomy is of course a time consuming operation, but those who have 
done a reversal procedure with a microscope will never revert to a macroscopical procedure 
again. Operating times vary between 2 –4 hours depending on the use of a one- or two-layer 
technique and the technical difficulties to encounter. Next to the difficult technical 
performance, it is frequently annoying that initial good sperm results can decline several 
months later. The cause of this decline is probably due to secondary stricturing because you 
initially start with semen samples of satisfying quality. Those patients undergoing a re-
vasovasostomy have even a greater chance of developing partial or complete stricturing of the 
new anastomosis area. That’s were our search for an alternative reversal method began.  
A permanently present hollow stent in the vas could be the solution. The literature reported on 
the use of stents especially in the 70’s, intravasal suture materials were used and polyglycolic 
acid as a bioabsorbable material became very popular in this decade. The results were 
promising but no further reports on this subject were seen in the years to follow. A possible 
explanation could be that supplementary studies in men were disappointing? 
At the end of the 1980’s, Berger et.al. restarted the use of a stent and published data from a 
study in men. His results were promising but not what he expected it to be. It appeared from the 
literature that nobody ever used a non-absorbable polymeric stent. After contacting several 
firms in the U.S., a couple of prototypes were realized. The big problem was to create a hollow 
stent that had small measurements and could also satisfy the condition of allowing sperm 
passage. We started to look for a suitable animal to test these prototypes and ended up with 
rabbits. They have an easy accessible vas deferens and the diameter of the vas equals that of 
men. Next to that, semen is easily obtained from these animals using an artificial vagina system 
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to collect sperm for an adequate follow-up. The biomaterial prototypes from the US were not 
successful and so we proceeded our search for a new stent that suited the purpose. We 
contacted the Technical University of Eindhoven, Eindhoven, The Netherlands and made an 
appointment at the biomaterials department. After explaining our ideas we were referred to the 
Center for Biomaterials in Maastricht, The Netherlands. We started to develop this stent using a 
non-biodegradable material. 
 
Development of a polymeric stent for vasovasostomy 
Development of a stent to rejoin two loose ends of the vas deferens requires a biomaterial that 
must meet several stringent requirements in terms of mechanical strength and biocompatibility. 
In situ, the stent has to withstand radial compression forces (especially those associated with 
peristaltic contractions of the vas deferens), to prevent narrowing or even closure of the stent 
lumen. With respect to the biocompatibility, two requirements can be formulated: (i) the 
presence of the stent should not evoke incompatibility effects, such as (chronic) inflammation, 
etc., and (ii) sperm cells should not be injured or damaged upon contacting the inner surface of 
the stent: epithelialization of the stents luminal surface should occur preferably.  
At the onset of this study, it was believed that these requirements could be met with a special 
type of hydrophilic-hydrophobic copolymers, i.e. those derived from the reactive monomer  
N-vinylpyrrollidinone (NVP) as the hydrophilic building block, and the reactive monomer  




Fig 1. Structural formulas of the NVP (left) and BMA (right) reactive monomers.  
 
Previous research has revealed the excellent biocompatibility (passivity) of such biomaterials, 
e.g., in contact with blood. Moreover, there is a wide range of NVP-based polymers and 
copolymers that find use in contact with human tissue (either in the clinic, or in cosmetic 
products). In our case, the ratio NVP:BMA provides a convenient handle to control the 
hydrophilicity, as well as the degree of swelling upon immersion in an aqueous environment, of 
the resulting copolymer. Furthermore, it was clear that the mechanical properties can be fine-
tuned by means of physical cross linking of the polymer chains, through introduction of a 
bifunctional reactive monomer during copolymer synthesis. For clarity: these mechanical 
properties refer to the swollen (wet) state, in which the stent biomaterial is saturated with water.  
In the dry state, the NVP-BMA-type copolymers are all hard and glassy materials, which can 
be machined with high accuracy and reproducibility. Upon absorption of water, however, the 
materials become more or less flexible and rubbery. 
Initially, a small number of prototype stents was manufactured out of a cross-linked version of 
the NVP-BMA copolymer. A number of preliminary experiments were performed, using the 
prototype stents and pieces of explanted vas deferens from an animal source. These preliminary 
experiments revealed two important points:  
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First, it became clear that joining of the two vas deferens ends by means of a simple 
intraluminal tube was inadequate. Most likely, such a tube can move along the intraluminal 
channel, especially as a result of the peristaltic movements of the vas during ejaculation. The 
stent was designed in such a way that longitudinal movements are prevented. This was realised 




Fig 2. Schematic drawing of the stent for vasovasostomy, as designed and tested during this 
project. 
 
The two vas deferens ends are joined on each side of the ridge, and connected through three 
stitches. This principle was used in all animal experiments with the stent for vasovasostomy, as 
described in this thesis.  
Secondly, it became clear that the implantation of the vasovasostomy stent is essentially a 
three-step procedure, i.e. (i), insertion of the first stent half into the lumen of one of the vas 
deferens ends, (ii), insertion of the other stent half in the other lumen; (iii), fixation of the vas 
ends over the stent ridge, by three stitches. It was found that steps (i) and (ii) are difficult to 
perform when the stent is already equilibrated with water, since the material is to soft and 
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rubbery. The implantation proceeds conveniently if the stent is implanted in its dry (rather stiff) 
state, and allowed to absorb water in situ. The implantation must be executed quickly, and dry 
gloves must be used. This implies that the hydrophilic swelling nature of the biomaterial can be 
used advantageously during the implantation of the stent. The implantation technique proved to 
be straightforward; the technique can be taught to the skilled professional surgeon within 
approximately 1 day.  
 
The experiment 
The prototype looked very promising and we started with the set-up of our animal experiment. 
Collection of semen was of outmost importance to prove that our stent would function 
adequately. In the middle of the province of Limburg in the Netherlands, we found a rabbit 
farm specialized in artificial insemination of rabbits. An artificial vagina semen collection 
system was demonstrated to us. A male and female rabbit were placed just above each other in 
a small cage but were initially separated from each other. The sexual arousal of these animals 
was impressing and within a few minutes the male and female rabbits were brought together. 
They started to cohabitate immediately and it was the experience of the owner of the 
insemination station at what exact time he had to put the artificial vagina system between the 
rear legs of the female rabbit. Within seconds the male rabbit ejaculated in the artificial vagina 
and the semen was collected in a tube that was connected to the artificial vagina. Average 
volume of the ejaculate varied between 1-1.5 cc. We decided to buy this system and after some 
practicing we became experts in collecting semen from rabbits. The prototype of the new stent 
fitted perfectly in the vas deferens of the rabbits and we used 2 rabbits for a pilot. Both 
produced sperm even after 2 months. What we didn’t know was how long it would take a 
vasectomized rabbit to become azoospermic. This was of importance because when a reversal 
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procedure would fail, due to complete obstruction, we would know the average time it would 
take for the animal to become azoospermic. Four rabbits were used for this experiment and 
after 6 weeks they all became azoospermic. Now it was time to start a randomized comparative 
study between rabbits that received bilateral stents and rabbits undergoing the conventional 
microscopic procedure. Together with the animal laboratory, we performed 28 vasovasostomy 
procedures and collected 142 semen samples. The animals were kept in cages, they were well 
nourished and postoperative care was taken care off. The animals were sacrificed 4-11 months 
after the initial operation and vas anastomoses, testes and epididymi were histologically 
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The aim of this review article is to explore from the literature what method of vasectomy 
produces the lowest risk of early recanalization and which vasectomy technique has the 
preference in an era where reversal of vasectomy is increasing. It is important to establish what 
is considered spontaneous recanalization. Early failure, defined as the presence of motile 
spermatozoa in the ejaculate four months after surgery 1, is usually attributed to technical error 
or to early recanalization of the vas. Early failure occurs in about one out of 300 vasectomies2,3. 
Late recanalization is described as the situation, were initially azoospermia is achieved and 
pregnancy is recorded afterwards, regardless of the time interval between azoospermia and 
pregnancy 4,5. Late recanalization is thought to be rare 0.04-0.08% 1,3  although in one study the 
rate of recanalization was 0.6 percent one year after vasectomy 2. In general, success after 
vasectomy is assessed after two consecutive azoospermic specimens 6-8. Persistence of non-
motile sperm after two semen analyses does not mean that success is not achieved. Most of the 
men become azoospermic within 1 year after vasectomy 7,9 . 
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Growing popularity of vasectomy  
 Vasectomy is a safe and effective method of permanent contraception. In 1995 approximately 
494.000 vasectomies were performed in the US (Haws et al) 10.  Vasectomy is less expensive 
and is associated with lower morbidity and mortality than tuba ligation 11,12. Hendrix et al. 13 
compared two methods of sterilization: bilateral tuba ligation and vasectomy. Compared were 
preoperative counseling, operative procedures, post-operative complications, procedure related 
costs, psychosocial consequences and feasibility of reversal. The complication rate in bilateral 
tuba ligation is 20 times higher and the mortality rate 12 times higher than in bilateral 
vasectomy. Tuba ligation is much more expensive compared to vasectomy. In 1987 in the USA 
a total of 976.000 sterilizations were performed (65% tubal ligation and 35% vasectomies) with 
an overall cost of $ 1.8 billion dollars. More than $ 800 million dollars could have been saved if 
80 percent of sterilizations would have been vasectomies, as was the case in 1971. Hendrix et 
al. concluded that the preferred method of sterilization is vasectomy because it is safe, most 
efficacious and least expensive. The decline in popularity of tuba ligation is pointed out in a 
British study by Rowlands and Hannaford 14. They estimated the incidence rates for tuba 
ligation and vasectomy and how these rates varied with age, geographical area and time. 
During the studied period from 1992-1999 there was a statistically significant 30% decrease in 
incidence of tuba ligation. The vasectomy rates did not change in time.   
Chinese made vasectomy a very popular form of contraception, illustrated by a complete 
reversal of the ratio male-to-female sterilizations in favor of vasectomy (3: 1) 15. Refining the 
technique of vasectomy, minimizing trauma, pain and complications, paved the way for the 
final breakthrough in the popularity of vasectomy.  Nevertheless, the success of the vasectomy 
procedure can be endangered by the markedly increased incidence of postoperative 
complications in the hands of surgeons that infrequently perform the procedure 16. 
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Early recanalization or successful vasectomy? 
The goal of each vasectomy is to obtain azoospermia. It is generally accepted that one or two 
azoospermic semen samples, taken 3-6 month after vasectomy, are sufficient for this statement 
17,18,19. But what if this azoospermia is not achieved and non-motile sperm persist? At what time 
and at which criteria do we state that recanalization has occurred?  Do patients with persistent 
non-motile sperm have a greater risk for late recanalization then those who had initial 
azoospermia? In other words, is special clearance (unprotected cohabitation with the presence 
of non-motile sperm) after one year of follow-up justified? Answering these question is 
difficult because only a limited number of studies have been published referring to these issues. 
In a study by Benger20 a survey was obtained from British urologist how they managed 
persistent quantities of motile and non-motile spermatozoa after vasectomy. There was a 56% 
response rate and from those responding, 23% never performed a revasectomy in case of 
persistent non-motile spermatozoa. They concluded from their study that the estimated risk of 
pregnancy occurring from the presence of non-motile sperm (sperm concentrations of one in 50 
to one in 100 high-power fields) is less than the established risk of late recanalization  (< 0.04-
0.1%). In a more recent (2001) survey17 among British general surgeons and urologist in the 
North-West region, protocols for post vasectomy semen follow-up were evaluated. Despite the 
fact that the majority of the protocols were not evidenced-based, the authors of this survey 
recommended a guideline that re-emphasized that the presence of non-motile sperm was not an 
indication for further sperm samples. The British Andrology Society18 set up a guideline (2002) 
for the assessment of post vasectomy semen samples. They evaluated seven studies on the 
subject of non-motile sperm after vasectomy. In their guideline they stated that when non-
motile sperm (<10.000/ml) was persistently seen after at least 24 ejaculations, the patient 
should be advised to discontinue contraception. The Australian Safety and Efficacy Register of 
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New Interventional Procedures-Surgical (ASERNIP)19 presented a 187 pages numbered report 
on post-vasectomy testing to confirm sterility. They recommended that special clearance should 
be given to patients with two consecutive samples of non-motile sperm <10.000/ml and not 
earlier then 7 month after vasectomy.  
Whether special clearance or even “normal” clearance in patient with non-motile sperm is 
justified, depends on the fact whether these patients have an increased risk on pregnancy 
compared to the patients with initial azoospermia and late recanalization. Philp et al.21 reported 
a late recanalization rate of 0.03% (6 from 16.796 men) and described no pregnancies after 
special clearance of 310 (2%) men with non-motile sperm (<10.000/ml) after vasectomy. 
Edwards and Farlow 22 reported similar results in 200 patients with non-motile sperm. From 
these 200 men, 190 were followed-up 12 to 15 months after vasectomy and no pregnancies 
occurred. Davies et al.23 reported no pregnancies after special clearance of 151 (2.5%) men 
with non-motile sperm (<10.000/ml) with a minimum follow-up of 3 years (3-8 years). There is 
no clear evidence in the literature (pub med search 1970-2005) proving  that pregnancies rates 
are higher in patients with special clearance after two or more non-motile sperm samples 
(<10.000/ml) compared to pregnancy rates resulting from late recanalization after initial 
azoospermia. Despite the absence of well designed randomized comparative trials there seems 
to be a tendency in literature to accept and justify special clearance in case of non-motile sperm 




The different vasectomy techniques and early recanalization 
Author’s technique: standing on the right side of the patient, the left vas is trapped between the thumb, index 
finger and middle finger, the right vas between only thumb and index finger. The left vas is located on top of the 
thumb, the right vas on the index finger. Lidocaine 2% (2cc) is infiltrated around the vas. A mid-scrotal 
localization is probably most convenient because in this area the vas is more straight and superficial. A 1 cm 
longitudinal incision is made and carried down through the vas-sheath until bare vas is exposed. The vas is 
delivered with a forceps or a clamp. The perivasal artery and veins are dissected from the vas. Preservation of 
these structures prevents possible complications like bleeding and thus hematoma. A segment of 2-3 cm is then 
excised, the stumps are occluded using suture material (Vicryl 2.0) and fascial sheath is interposed. The small 
cutaneous wounds are closed using 4.0 Vicryl Rapide. This technique is one of the many modifications of the 
conventional technique.   
 
No-scalpel technique 
Li 25 presented a no-scalpel technique. This method eliminates the scalpel and results in fewer 
hematomas and infections. A ring tipped vas deferens clamp is used and placed over the vas 
deferens after digital fixation of the vas under the median raphe. The skin in the clamp is tightly 
stretched over the most prominent portion of the vas and a sharp pointed mosquito is punctured 
through the overlying skin, into the vas sheath and vas wall. The clamp is gently opened until 
the bare vas wall can be visualized. The blades are turned 180 degrees and the vas is luxated 
through the puncture opening, divided and occluded.  
Several studies compared the no-scalpel technique with the conventional technique and 
concluded that the no-scalpel technique resulted in a markedly reduced incidence of infection, 
hematoma and pain 26,27,28. The time needed for the no-scalpel technique was 40 percent less. 
The technique is more difficult and requires intensive hands-on training. Sokal et al.29 
presented a multicenter, randomized partially masked controlled study and found no difference 
in success rates between the conventional and the no-scalpel technique. The no-scalpel 
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technique had the advantage of shorter operating time with fewer complications and reduced 
perioperative discomfort. However, Alderman and Morrison30 who reviewed the records of 619 
consecutive vasectomies, could not confirm these advantageous claims.  
 
Percutaneous vasectomy 
Percutaneous vasectomies have been performed by Li 31 and Ban32 using a combination of 
cyanoacrylate and phenol. The vas lumen was punctured with a 22 gauge needle and the 
position was confirmed injecting methylene blue into the left vas as well as Congo red into the 
right vas. Injection of 20 micro liters of two parts phenol mixed with one part n-butyl 2-
cyanoacrylate mixture via the 22-gauge blunt-tipped needle occluded the lumen. Brown 
coloring of urine (blue and red) confirmed that both sides were occluded. Chen and co-workers 
33 performed vas occlusion in 53 men, using injection of 0.16-0.22 ml polyurethane elastomer. 
They reported azoospermia rates of 85% after one year and 96% after two years. They stressed 
the fact that the shape of the intravasal plug was of great importance for successful vasectomy 
rates.  Zambon et al.34 investigated the efficacy of a percutaneous vas occlusion using silicone 
plugs. Significantly fewer men were azoospermic after vas occlusion than after conventional 
vasectomy. They concluded that the reliability of percutaneous vas occlusion is poor and 
should be rejected. In general, using techniques of percutaneous injection of an erosive agent in 
quite a length of the vas deferens has the disadvantage of permanent irreversibility.  
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Suture ligatures, clips and cautery 
Suture ligatures, still the most common method employed worldwide may result in necrosis and 
sloughing of the cut end distal to the ligature. On the testicular side a sperm granuloma may 
develop. If both ends slough, recanalization is more likely to occur 35  vasectomy failure rates 
due to recanalization vary from 1-5 % when only ligatures are applied for occlusion. 
When using hemoclips, failure rates are less than 1% 36,37. The more equal distributed pressure 
on the vas wall results in less necrosis and sloughing. Intraluminal cautery, destroying mucosa 
over at least one cm length, reduces recanalization rates to less then 0.5 %38. Labrecque et al.39  
investigated 3761 men who underwent initial vasectomy. The vasectomy failure rates in the 
clipping and excision group were much higher than in the cautery, interposition and open 
testicular end group (8.7% versus 0.3%). A prospective, non-comparative multicenter 
observational study was conducted by Barone et.al 40.  A total of 364 men completed follow-up 
in this study and were followed for 6 months. Each site used their usual cautery vasectomy 
technique. The overall failure rate based on semen analysis was 0.8% (95% confidence interval 
0.2, 2.3). By 12 weeks 96.4% of participants showed azoospermia or severe oligozoospermia  
(< 100,000 sperm/mL). The predictive value of a single severely oligozoospermia sample at 12 
weeks for vasectomy success at the end of the study was 99.7%. Sokal et.al 41 compared semen 
analysis data from men following vasectomy using two occlusion techniques. Data on 
intraluminal cautery came from a prospective observational study conducted at four sites. Data 
on ligation and excision with fascial interposition came from a multicenter randomized 
controlled trial that evaluated the efficacy of ligation and excision with versus without fascial 
interposition. Ninety-seven percent of the men in the cautery study had reached success by 12 
weeks, while only 91% in the fascial interposition study had reached success by 14 weeks. The 
difference in the observed failure rates suggests that vas occlusion techniques that include 
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cautery are significantly more effective than ligation and excision plus fascial interposition, at 
least based on semen analysis. 
 
Importance of vas length removed 
The length of the vas removed has an impact on the failure rate. Removal of quite long parts, 
reduces the chance of recanalization 16, but is associated with more complications like 
hematomas and it impairs successful vasectomy reversal in the future. Hallan and May 42 
studied 30 bilateral vasectomized men. After excision of the vas segment, X-rays were taken to 
assess the actual radiologic separation of the vas ends. After a median excision of 22.5 mm of 
vas, the median radiological gap took about 7 mm. They concluded that a very long segment 
(>7cm) should be excised to achieve a gap greater than that of sperm granulomas associated 
with vasectomy failures. Therefore they suggested that only short segments can be excised but 
that additional procedures, like interposition and/or fulguration, are necessary to prevent 
possible recanalization. In a more recent study by Labrecque et al.43, the length of the vas 
resected during vasectomy had no influence on the risk of postvasectomy recanalization. They 
compared a group of spontaneous recanalizations with a group of azoospermic patients and a 
group of patient with non-motile sperm (<1x106 /mL). In cases of spontaneous recanalization 
versus azoospermic patients, the risk ratio (95% confidence interval) of recanalization with an 
average of segments of <10mm and 10-14mm was 0.6(0.1-2.0) and 0.6 (0.2-1.6) when 
compared to 15mm or more, respectively. In cases of spontaneous recanalization versus non-
motile sperm group the risk ratio was 1.6(0.4-7.7) and 0.6 (0.2-1.7), respectively.  
Clenny and Higgins35 evaluated several vasectomy techniques and concluded that removal of at 
least 15 mm vas is recommended although plain cutting of the vas without removal is effective 
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as well in combination with adjusted techniques for handling the vas ends like folding, luminal 
fulguration and proximal fascial interposition. 
 
Role of fascia interposition and/or folding back of vas ends 
Interposition of fascia between the cut ends, folding back of the vasal ends and securing one 
end within Dartos muscle have all been advocated to reduce failure rates. In 1995 Schmidt 44 
presented a series of 6248 vasectomies, all performed by one surgeon. No vasal segment was 
resected and the intraluminal mucosa of the cut ends was destroyed by fulguration after which 
the vas sheath was interposed preventing possible recanalization. In a period of 38 years he 
documented no persistence of sperm and post-vasectomy pregnancies. In 1994 Li et al. 45 
published the results of a series of 2713 vasectomies using 7 different occlusion techniques. 
Especially the two techniques that used fascia interposition provided the best results.  
Sokal et.al 46 performed a well conducted randomized trial to compare the probability of the 
success of ligation and excision vasectomy with, versus without, fascial interposition. All 
surgeons performed the vasectomies using the no-scalpel approach to the vas. Participants had 
a semen analysis two weeks after vasectomy and then every four weeks up to 34 weeks. The 
primary outcome measure was time to azoospermia. Additional outcome measures were time to 
severe oligozoospermia (<100 000 sperm/mL) and vasectomy failure based on semen analyses. 
Recruitment after the planned interim analysis was halted, when 841 men had been enrolled  
(interim analyses was separately published by Chen-Mok 47). Fascial interposition decreased 
time to azoospermia (hazard ratio [HR], 1.35; P < 0.0001) and time to severe oligozoospermia 
(HR, 1.32; P < 0.0001) and reduced failures based on semen analysis by about half, from 
12.7% (95% confidence interval [CI], 9.7 to 16.3) to 5.9% (95% CI, 3.8 to 8.6) (P < 0.0001). 
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Further recruitment was terminated prematurely. This study was one the first providing data 
from a randomized prospective trial showing the significant benefit of fascial interposition. 
Open ended vasectomies have been advocated in the 70’ties. Sperm granuloma development at 
the testicular open end had the advantage of preventing irreversible damage to the testis, 
improving the chances of successful reversal, but they provided unacceptable vasectomy failure 
rates varying from 7-50 percent 48,49. In a larger series by Errey and Edwards 50 the risk of 
spontaneous recanalization was much less. They compared 4330 open-ended vasectomies with 
3867 standard vasectomies and spontaneous recanalization was rare in both groups.  
Haws et al.10 provided nation wide data on the numbers of vasectomies, various occlusion 
techniques, fascial interposition and on protocols for semen follow-up in the United States. 
About one third of vasectomies in 1995 were no-scalpel vasectomies. The most common 
occlusion method was ligation and cautery. Less than half of the physicians (48%) interposed 




From these studies we conclude that the risk of pregnancy resulting from recanalization in 
patients with non-motile sperm is no greater than in those with two consecutive azoospermic 
semen samples 52,46,9,20,21,22 . Therefore persistence of non-motile sperm after one year of 
follow-up should not automatically be diagnosed as recanalization but rather as residual sperm 
higher up in the urogenital tract 53. In our practice we perform a semen check-up after 3 
months, if this indicates azoospermia or non-motile sperm in a concentration of < 100.000 non-
motile sperm; no further semen specimens are analyzed. This is in accordance with the recently 
published guideline vasectomy of the Dutch Urological Society 54. The only absolute proof for 
recanalization is undoubtedly histological investigation of a patent section at the time of the 
revasectomy. In daily practice this investigation is not applied. We do believe that recurrence of 
motile sperm during follow-up is evident proof of recanalization. In case of only several motile 
sperm cells in the ejaculate a repeated semen specimen can be taken 4 weeks later to confirm 
the persistency of this recurrent and probably enhanced motility of sperm. In such a case 
revasectomy is indicated. 
There seems to be a relationship between the kind of vasectomy procedure and the risk of 
recanalization. Simple suture ligatures, resulting in necrosis and sloughing of both ends, 
provides the highest risk of recanalization and should therefore in our opinion be abandoned. 
The length of the vas resected during vasectomy is still under discussion, fascial interposition 
and/or folding back of vasal ends are probably of much greater importance. Those who perform 
vasectomies at regular bases are familiar with the fact that despite excision of a 2 cm vas 
segment the cut ends are still in close contact with each other. Therefore many surgeons will 
fall back to additional techniques like interposition or folding back to assure them that these 
ends will not meet and possibly recanalize. We are convinced that resection of a vas segment 
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<2cm provides limited contribution in preventing recanalization. Taking in account the studies 
with greater series it seems that cautery of the abdominal end, over a length of at least 1cm, in 
combination with interposition of vas sheath and an open-ended testicular side, is the preferred 
method of choice. These open ended vasectomies have several advantages. Leaving the 
testicular side open has the possible advantage of less post vasectomy chronic pain due to 
sperm granuloma formation 55,56. Due to the development of sperm granuloma formation at the 
open testicular end, a pressure release valve can develop, reducing damage to the epididymis 
resulting in more successful vasectomy reversals. In an era with so many divorces and restored 
child wish with a new partner, long resection of vas should be carried out with restraint. 
Although there are from the literature only a limited number of well designed randomized 
comparative studies in this review, we are convinced that we have to modify our current, 
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In our clinic, we perform two consecutive semen examinations at 6 and 12 weeks after a 
vasectomy. If the final examination shows azoospermia, the patient is given clearance to have 
intercourse without contraception. 
Recently, we observed that a large portion of the patients had persisting nonmotile sperm even 
12 weeks after vasectomy. This resulted in repeated semen examinations and some patients 
underwent revasectomy. This uncomfortable situation caused us to search for the probable 
cause and significance of nonmotile sperm and the best way to deal with this clinical problem. 
 
Materials and Methods 
Vasectomies were performed by six different urologists. All the procedures were done on an 
outpatient basis under local anaesthesia with lidocaine 1 %. After luxation of the vas deferens, 
a 1 to 2 cm long segment of vas deferens was resected and submitted for histological 
confirmation. During the vasectomy procedure, both vas ends were ligated with vicryl 1.0 and 
spermatic fascia was interposed. If the semen examination at 12 weeks postvasectomy showed 
azoospermia, the patient was given clearance to have intercourse without contraception. If 
residual sperm was found at 12 weeks postvasectomy, semen examinations were repeated until 
azoospermia was seen. Semen examinations were done by our infertility laboratory. Twenty 
fields of noncentrifuged semen samples were investigated under the microscope with an x200 
magnification.  
The vasectomy procedure and the semen analysis have not changed over the last 10 years. 
Review of the semen analyses (≥12 weeks after vasectomy) was done in 413 patients who 
underwent vasectomy in the period between April 1st, 1993 and July 31st, 1995. A letter was 
written to all 413 patients. In the letter, a new semen sample was requested. In an added 
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questionnaire, we asked for the occurrence of possible pregnancies. Because 62 letters were 
returned by the postal service, we concluded that 351 patients received our inquiring letter. 




From the 413 patients who underwent a vasectomy, 395 patients delivered a semen sample 12 
weeks after vasectomy. Azoospermia was found in 262 of 395 (66%) patients. Nonmotile 
sperm after vasectomy was found in 130 of 395 (33%) patients who delivered semen 12 weeks 
after vasectomy. The sperm count varied from 2.30 to 1.65 X 106/mL (nonmotile sperm). Of 
130 patients with persisting nonmotile sperm, 91 (70%) men continued to deliver semen 
samples after 12 weeks postvasectomy. In this group of 91 patients, azoospermia was found in 
87 (96%) patients after a mean follow-up of 6.36 months (3 to 21 months). Even a patient with 
a sperm count of 1.65 X 106 nonmotile sperm 12 weeks after vasectomy achieved azoospermia 
10 months postvasectomy. There was no significant difference between the group of patients 
with azoospermia and the group with nonmotile sperm 12 weeks postvasectomy with regard to 
mean age and length of resected vas deferens. Table 1 shows data of the group with nonmotile 
sperm 12 weeks after vasectomy. 
Table 1. Patients with nonmotile sperm 12 weeks postvasectomy 
 
                                                                                          Mean             Minimum      Maximum 
 
Resected vas (cm) (n=127)                                                 1.2                     0.4                   2.8 
 
Age(years)  (n=130)                                                         38.4                       28                   58 
 
Sperm concentration (x103/mL)                                         79                      2.3               1.650 
(n=130) 
 
Months to azoospermia (n=87)                                        6.36                        3                    21 
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From the 91 patients with persisting nonmotile sperm, 4 patients underwent revasectomy 
because of unacceptable duration of persistent nonmotile sperm concentrations. After 
revasectomy, two patients still had unchanged concentrations of nonmotile sperm 12 weeks 
after the revasectomy (Table 2). Pathological investigations of the resected specimens at 
revasectomy showed in only one case a sperm granuloma that could suggest a possible re-
canalization. 
 
Table 2.  Semen analysis of  four revasectomy patients (nonmotile sperm) 
 
     Patient                                                       1                      2                        3                        4                  
 
                                                                                                      x103 /mL 
 
Before vasectomy  *                                    7.5(10)               20 (9)                7.5 (9)                15(5) 
 
12 weeks after vasectomy                               0                     20                      7.5                       0 
 
*values in parentheses are months between first vasectomy and last semen analysis before revasectomy 
 
Only 65 of 351 (18.5%) men replied to the letter and provided a renewed specimen together 
with their questionnaire. From the 65 men who delivered a further semen sample, 53 (82%) had 
azoospermia. Nonmotile sperm was found in 12 of 65 men (18.5%). Reappearance of 
nonmotile sperm after initial azoospermia (at 12 weeks) was found in 5 of 65 men (8%)  








Table 3.  Five patients with reappearance of nonmotile sperm after azoospermia  
Patient                             months to                     months to reoccurrence             No. of sperm/mL 
                                       azoospermia*                  of non motile sperm** 
 
      1                                     7                                         12                                                7.500 
 
      2                                     5                                         12                                              20.000 
 
      3                                     7                                         18                                            150.000 
 
      4                                     3                                         20                                                7.500 
 
      5                                     7                                         22                                                7.500 
*   after vasectomy 
** after previous azoospermia 
 
The five patients with reappearance of nonmotile sperm (longest follow-up 22 months) did not 
report any pregnancies. Only one patient in this group had repeated semen examinations (five 
times) because of persistent nonmotile sperm. 
Early recanalization was found in 3 of 395 of the patients (0.75%) who delivered semen 
samples within 12 weeks after their initial vasectomy (Table 4). One pregnancy occurred 
among these patients because of the fact that the concerned patient (patient 3) had unallowed 
unprotected intercourse before his final semen control at 12 weeks postvasectomy. 
 
Table 4. Sperm analysis of three patients with motile sperm* 
 
   Patient                                       at 6 weeks                                             at 12 weeks 
 
                                                                     x106/mL                                                                    x 106/mL 
 
 
       1                                              7(0)                                                          12(60) 
 
        2                                             13(30)                                                         5(25) 
 
        3                                               0                                                             21(50)                                
 




Renewed patency or pregnancy after vasectomy can have several causes. Technical error, early 
recanalization, and residual motile sperm in the seminal vesicle after vasectomy are causes that 
can be detected easily by the presence of motile sperm, in various concentrations, in the 
postvasectomy specimen. 
In the literature, a distinction is made between early and late recanalization. Early 
recanalization can be detected by an increasingly large amount of motile sperm in the 
postvasectomy specimen. Late recanalization is the presence of motile sperm after the 
postvasectomy specimen(s) showed azoospermia. Late recanalization can occur several years 
after vasectomy and usually is detected only after a pregnancy has occurred 1. All the above 
mentioned causes of patency and pregnancy refer to motile sperm. 
But what about nonmotile sperm? Can nonmotile sperm cause pregnancy? Is the presence of 
nonmotile sperm a signal that patency of the vas is present, meaning that the patient with 
nonmotile sperm has a higher risk of causing pregnancy compared with a patient with 
azoospermia? Persisting nonmotile sperm after vasectomy is a known phenomenon. Philp et al. 
2 reported no pregnancies after special clearance of 310 (2%) men with nonmotile sperm 
(<10,000/mL) after vasectomy. Davies et al.3 also reported no pregnancies after special 
clearance of 151 (2.5%) men with nonmotile sperm (< 10,000/ mL), with a minimum follow-
up of 3 years after vasectomy. Edwards and Farlow 4 gave clearance to 200 men with 
nonmotile sperm (30 patients with 500,000/mL and 2 patients with 24 X 106/mL). 
Of these 200 men, 190 were followed up 12 to 15 months after vasectomy and no pregnancies 
were reported, even though 5 of 48 men who submitted a semen specimen still had nonmotile 
sperm. In a study published by Edwards 5, patients tested 4 weeks after vasectomy, regardless 
of the amount of postvasectomy ejaculations, were given clearance if no motile sperm was 
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found. An important detail in this article is that five cases are mentioned in which the initial 
tests showed a count of 16 x 106 to 33 x 106 nonmotile sperm. These patients had repeated tests 
after a few weeks and a marked reduction in numbers of nonmotile sperm was observed. In the 
same paper, Edwards reported two pregnancies on a total of 3,178 vasectomized men; both 
patients had a recanalization of the vas deferens proven by motile sperm in the semen analysis. 
From the above mentioned data, one can conclude that patients with persisting nonmotile 
sperm postvasectomy have a very low risk of causing pregnancy. 
If we search for proof to the contrary, one case report 6 can be found in which a patient with a 
small number of nonmotile sperm after vasectomy caused a pregnancy. Paternity was 
ascertained by DNA profiling in this case. Even more confusing is the article by Smith et al.7 in 
which they present six cases of DNA-proven fatherhood caused by azoospermic men. They 
explain this phenomenon by the intermittent production of viable sperm. Still, these few data 
do not prove that men with nonmotile sperm after vasectomy have a higher risk of causing a 
pregnancy then azoospermic patients. 
In our study, 96% of the patients returned and delivered a semen sample at 6 and 12 weeks 
postvasectomy. This is a high patient compliance rate compared with the 64% mentioned by 
Belker et al. 8 and the 71% mentioned by Edwards 5 . 
In our study, we found that 33% of our patients had nonmotile sperm 12 weeks postvasectomy. 
Edwards 5 found that 42% of his patients had nonmotile sperm between 7 and 14 weeks 
postvasectomy. From the group of patients with persisting nonmotile sperm that continued to 
deliver semen samples, 96% became azoospermic in our study. 
The persistence of nonmotile sperm in two cases after revasectomy in our study only can be 
explained by residual sperm in the seminal vesicles or the abdominal part of the vas, because 
large pieces of the vas were resected at the revasectomy and no recanalization was found after 
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microscopic investigation of the resected pieces. 
Reappearance of nonmotile sperm after azoospermia was found in 8% of the volunteer group. 
The highest count was 150,000/mL. No pregnancies were found among these patients with a 
maximum follow-up of 22 months. 
In a recent article by O'Brien et al.9, temporary reappearance of sperm 12 months after 
vasectomy is described in six cases (0.6%). The sperm count was <10,000/mL. Unfortunately, 
the percent motility of the sperm is not mentioned in this article, which is essential information 
if one is to say anything on the chance of causing pregnancy. 
Based on the literature and on our own experience, we assume that men with small amounts  
(<1 x 106) of nonmotile sperm after vasectomy have a very low risk of causing pregnancies. 
Probably this risk is comparable with the risk that azoospermic men generate pregnancies. 
For this reason, we give clearance to patients who have small amounts of nonmotile sperm 12 
weeks after vasectomy. Our hypothesis is that persistence and reappearance of nonmotile 
sperm after vasectomy is caused by release of nonviable residual sperm in the seminal vesicles 
and the abdominal part of the vas deferens. This is supported by the observation that nonmotile 
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The microsurgical technique 
In the early beginning vasovasostomies were done macroscopically. Macroscopic 
reapproximation represents the development of an anastomosis done without any type of 
optical magnification 1, 2. Because microscopical reconstructions led to better results compared 
to macroscopical reconstructions 3,4,5,6, we switched over to the microscopical procedure. 
Before starting with microscopical reconstructions one should follow a course on microsurgery. 
Spending a whole week reconstructing blood vessels in rats in a microsurgical-training center 
in Rotterdam, The Netherlands was a good training. It is important to learn the proper hand and 
finger positions for holding microsurgical instruments; ergonomic principles to prevent hand 
and finger tremors and functioning of the various parts of the operating microscope. Optical 
loupes can be used. Optical loupes with 2.5x to 3.5x are used commonly by surgeons to 
visualize fine structures in the operating field. Structures more then 3 mm in diameter can be 
optimally approached with optical loupes. But for smaller structures an operating microscope is 
absolutely necessary. The disadvantage of optical loupes is the fact that the surgeon must hold 
his head virtually motionless in order to keep the structures in the operating field in focus.  If 
the power of magnification increases it is even harder to maintain a fixed focus. 
Operating microscopes provide light that is coaxial to the field of view and offers adequate 
illumination of the operating field 7, 8, 9. In contrast with the surgical loupes, focusing of the 
microscope is done electronically by moving the head of the microscope rather then moving 
your own head which is time consuming and less precise. Eyepieces are available in several 
strengths and diopter scales are provided on the eyepiece for individual adjustment. Double 
vision should be corrected by adjusting the interpupillary distance. This binocular view permits 
stereoscopic viewing. Most microscopes have binocular tubes that can be adjusted to various 
angles. We use a diploscope arrangement in our operations. A diploscope configuration is 
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useful for most microsurgical procedures. The eyepieces of the surgeon are directly opposite 
the eyepieces of his assistant. Such an arrangement uses a single objective lens and a beam 
splitter to provide the surgeon and the assistant with one-half of the available light each. The 
advantage of this system is that the assistant uses the same amount of magnification as the 
surgeon. The cooperation is in this way more efficient. The magnification changer permits 
variation in magnification. In our setting it is controlled automatically by a foot pedal. The 
length of the binocular tubes, the power of the eyepiece, the properties of the magnification 
changer and the focal length of the objective lens determine magnification. Objective lenses are 
available in focal length ranging from 150-400mm. For each 25 mm increase in focal length, 
the objective lens will focus 25 mm farther away from the operating field.  Magnification 
decreases, and the size of the field of view increases, as the focal length of the objective lens 
increases. If the focal length is to short than the surgeon is forced to assume a kyphotic position 
if it is too long he is required to stand up. This illustrates that optimal care has to be taken for 
the exact positioning of the microscope because non optimal visualization can be of bother 
during the entire operation. Good positioning can also be achieved by adjusting the organs in 
the operating field and prevent unnecessary disturbing reflection from light. Our microscope is 
mounted on a floor stand and contains a horizontal suspension arm. After macroscopically 
preparing the operation field the microscope can easily be directed towards the surgeon and his 
assistant, taking in account the principles of sterility. If the focal length is difficult to install one 







What kind of microsurgical instruments do we need?  
First of all the microsurgical instruments should be demagnetized. Because most microsurgical 
instruments are made of stainless steel (as in our hospital) instruments may become 
magnetized. The surgeon experiences difficulty in picking up needles with a magnetized 
instrument. Titanium is an alternative but very expensive. The gloves used should not be too 
slippery. The movement of the instruments in the hand should be optimally controlled. Gloves 
that provide a certain roughness provide a more sufficient control of the instruments. 
(Supersensitive, Biogel ®). Microsurgical instruments are extremely delicate. Dropping such 
an instrument could lead to irreversible damage. Therefore the instruments are kept in a special 
tray designed for protection. Tip covers are useful and highly recommended. Having your own 
instruments is an advantage, because providing these instruments to other surgeons could 
invariably lead to damage or loss. During the procedure the instruments should be cleaned and 
the deposition of blood cloth between the blades prevented. Cleaning can be done in water 
using a surgical sponge and dried. Using round handles for the instruments makes it easier to 
manipulate compared to flat handles. Pro- and supination is simplified so the needle can be 
passed easier through the tissue. There are various needle holders. You have nonlocking and 
locking needle holders. We prefer the nonlocking holders because it prevents grove movements 
if you want to reposition the needle holder. Next to that, uncontrolled unlocking may give rise 
to tear through the tissue and may influence the water tightness eventually. In performing an 
operation we need 2 needle holders, 3 or 4 forceps, preferably Harms forceps with platforms on 
the end of each blade for easy pick up of needles, 2 scissors (cutting tissue and trimming vessel 
ends and cutting ligatures), vas dilator (judging elasticity and dilation to ease introduction of 
the needle) and an approximator. We use a Silber folding approximation clamp. During the 
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operation we use bipolar cautery to prevent damage to the anastomosis and vascularity of the 
vas. 
Underneath the area of the newly developed anastomosis, we place a blue flexible thin plastic 
slip. The advantages are multiple: less reflection of light, reduced distraction from the 
surrounding tissues, perfect overview over the anastomosis due to less disturbance of  blood 
flow over the operation field and finally no hooking of the needles in the surrounding tissues 
with facilitates pulling through of the loops of the sutures. We use 8.0 prolene sutures double 
armoured with flat needles (30-150 micrometer) allowing the surgeon to hold the needle more 
securely.  Important is that the forearms are supported by the table to prevent any form of 
tremor. We always use double armoured sutures so that we can be sure that the needle goes 
from the inside through the mucosal edges towards the outside of the vas wall. We start at 6 
o’clock, and this first suture is tied. Then we place 3 or 4 additional sutures anti-clockwise at 
the corresponding area’s (3, 12 and 9 o’clock) of the vas. These separate sutures are covered to 
prevent strangulation of the loop ends. After placing all the sutures there is a final check to be 
sure that the position of the sutures is congruent over both vas ends so that torsion is prevented. 
Magnification for tying the sutures can be reduced which makes it much easier to perform. To 
check the water tightness of the anastomosis, we compress the area of the epididymis if no 
sperm leakage is observed we end the operation. If there is still some leakage we place an 
additional serosal suture at the place of the leakage. A final check is done for hemostasis and 
the vas is replaced in the scrotal area. Tunica dartos is closed with 4.0 Vicryl and the skin is 
closed with 4.0 Vicryl Rapide. A tight short with drapes at the wound area is attached and after 
a final wound check at the end of the day the patient is dismissed from the hospital. At 2 weeks 
there is a wound inspection and the first semen check will be done 5 weeks later. Semen 
analyses will be done with an interval of three months. If the quality of the sperm after 1 year 
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remains poor and insufficient for a spontaneous pregnancy, the couple is send to the 
gynecologist for IUI, IVF or ICSI or in case of azoospermia a renewed vasectomy reversal is 
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Vasectomy is a very popular form of birth control. The request for vasovasostomy procedures 
is growing due to the increasing prevalence of divorce and remarriage. However, the number of 
reversal procedures in this hospital has not increased over the last decade. The aim of the study 
was to investigate the results of vasovasostomy procedures in relation to duration of 
obstruction and preoperative serum agglutinin titres. Obstructive interval is defined as the 
period between vasectomy and refertility. In previous studies the correlation between 
obstructive intervals and pregnancy rates has been demonstrated 1, 2. Especially in the study of 
Kabalin and Kessler 2 a 5-year obstructive interval seems to be a critical barrier in achieving 
acceptable pregnancy and patency rates. Even with obstructive intervals exceeding 10 years, 
pregnancy can still occur 1. 
 
Materials and Methods 
 
A total of 82 primary vasovasostomy procedures were performed between January 1983 and  
December 1991 and 66 patients were admitted to the study. Sixteen patients were lost to 
follow-up. Average age was 37 years (26-59) and the mean follow-up was 54 months (5-105). 
After the medical history had been obtained and clinical examination (to exclude sperm 
granulomata) had been carried out, sperm agglutinating antibodies in serum were determined 
by means of a standard tray agglutination test (TAT). In this procedure, heat inactivated 
serially diluted samples were incubated with donor sperm. These samples were then placed in 
microchamber trays under paraffin oil at 37°C. After 2 h the results were read using an inverted 
microscope. 
Obstruction intervals were subdivided in categories varying from 0-2, 2-5, 6-10 and more than 
10 years after vasectomy. Bilateral vasovasostomy was performed in 62 patients. One patient 
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underwent a unilateral reversal procedure and in 3 others a bilateral vasoepididymostomy was 
carried out. 
The patients were operated on by different surgeons and the macroscopic procedure was more 
often performed than the microscopic (62% vs. 38%). All the anastomoses were constructed 
with double-ended prolene 7.0 one-layer sutures. Microsurgical vasoepididymostomy was 
performed by using an end-to-end anastomotic method. In 53% (n = 35) of the patients an 
internal splint running through the anastomosis of the vas deferens and leaving the scrotum, 
was left in situ for 24 h. Postoperative semen analyses were determined 2 months, 6 months 
and 1 year after reversal or until pregnancy occurred. Sperm counts were subdivided into 4 
groups: 0, < 10, 10-20, > 20 millions/ml. Those patients who had recurrence of sperm in the 
semen after a 1-year follow-up, but had not reported pregnancy, were contacted by telephone. 
 
Results 
There were various reasons for regaining fertility. In 50% (n = 33) of all cases the desire to 
have a child with a new partner, resulting from a previous divorce, was reason for a reversal 
procedure. The wish to have more children within the same marriage accounted for 35%  
(n = 24) see (table 1). 
Table 1.  Reasons for vasectomy reversal 
 
                                                                                                                     Patients 
 
                                                                                                           n                               % 
 
Divorce and remarriage                                                                     33                             50 
 
Child died                                                                                            3                               5 
 
Wife died                                                                                             3                               5 
 
Desire for (an) additional child                                                          24                             35 
 
Other                                                                                                    3                              5 
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Patency was described as the recurrence of sperm in the ejaculate after vasal reconstruction. 
Postoperative sperm counts were correlated to duration of obstruction (table 2).  
 
Table 2. Obstructive interval compared with postoperative sperm concentrations in 66 patients 
 
Obstructive                                            Sperm concentrations, million/ml 
interval 




0-2                            3                       -                  -                    1(33%)             2(67%) 
 
2-5                           28                      -                  6(21%)          6(21%)           16(58%) 
 
6-10                         27                     7(26%)        5(18%)          3(11%)           12(45%) 
 




As the latter became shorter the mean sperm count rose significantly. The fact that a patency 
rate of 100% occurred if the time to reversal was less than 5 years (fig. 1) was a remarkable 
finding. As the obstruction period became longer, the number of failures rose. An overall 
patency rate of 84.8% was achieved. Taking a 5-year obstruction interval under review, a 
pregnancy rate of approximately 67% (fig. 1) was obtained. Obviously there is a clear 
discrepancy between patency and pregnancy rates probably due to low postoperative sperm 
counts and/or circulating antisperm antibodies. Nevertheless, pregnancy occurred in 25% (2/8) 








Fig 1. Obstructive interval versus patency and pregnancy rate in 66 patients 
 
Preoperative antisperm antibodies in serum were determined in 35 patients. Despite the fact 
that a limited number of patients were studied, it seemed obvious that there was a correlation 
between the titre and the appearance of pregnancy after reversal (table 3). With serum 
agglutinin titres of < 1/32 there was a significantly better chance of obtaining pregnancy. 
Nevertheless, pregnancy occurred in 23% (3/13) of the patients with an agglutinin titre of 1/64. 





































Table 3. Preoperative serum sperm agglutination titres correlated with pregnancy rates in 35 patients 
 
Agglutination                                    Patients                                                          Pregnancies 
Titres 
                                                                                                                            n                                 % 
 
Negative                                             10                                                            8                                 80 
 
1/4                                                        4                                                            2                                 50 
 
1/16                                                      3                                                            2                                 66 
 
1/32                                                      3                                                          nil                                nil 
 
1/64                                                    13                                                            3                                 23 
 




This study illustrates once more that there is an obvious relation between the duration of the 
obstructive interval and postoperative pregnancy rates. Previous studies have illustrated the 
same phenomenon. Silber 3 indicated in his study in 1977 that patients with intervals of 10 
years or more had poor chances for fertility. Nevertheless, we believe that such long intervals 
should not deter a surgeon from performing a reanastomosis. An important prognostic factor is 
whether the vas fluid coming from the testicular vas end contains spermatozoa. Belker and 
Bennett 4 suggested that the fluid obtained intraoperatively from the testicular vas end should 
be examined microscopically to decide whether vasovasostomy or vasoepididymostomy should 
be performed. In this series we only observed macroscopically if fluid was coming from the 
testicular end and no microscopical examination was carried out. The use of an internal splint 
during the operation has frequently been discussed. Several studies reported on the use of an 
absorbable polyglycolic acid tube stent in rats and dogs 5, 6. There seemed to be a superior re-
epithelialization and closer return of the vas to normal morphology in polyglycolic stented 
anastomoses, than in anastomoses created with the conventional two-layer technique. 
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Reduction of perivasal inflammatory reaction (probably due to sperm leakage), ease of anas-
tomosis with satisfactory approximation of vasal ends and maintaining luminal patency, are 
several other advantages claimed for with this stent. In the present series a prolene 0 wire was 
used as a splint and it was carried up through the proximal end of the vas deferens and then led 
into the distal part where it left the vas transmurally through a hollow medical needle. In this 
way the creation of the anastomosis with double-ended prolene 7.0 was facilitated. The use of a 
carbon dioxide (CO2) laser in creating an anastomosis has been previously described by 
several authors. Rosemberg 7 presented his results with this technique in 1988. He 
demonstrated postoperative sperm counts of over 20 million/ml in 86% of the patients and a 
pregnancy rate of 43% in the group of patients operated on within 10 years of the vasectomy. 
The influence of antisperm antibodies upon fertility after vasectomy is a well-known 
phenomenon. Matson et al.8 noticed the fact that conception rates were reduced in those 
couples in whom the presence of IgG or IgA+IgG antisperm antibodies occurred in seminal 
fluid. Meinertz et al.9 also stressed the finding that especially the occurrence of 19A in the 
seminal fluid was associated with low conception rates. Aitken et al. 10 described the capacity 
of antibodies to stimulate or suppress sperm/oocyte fusion. In vasovasostomized patients they 
saw a higher stimulating effect on this fusion than in patients with primary infertility. In their 
series they observed no correlation between the titre of antisperm antibodies and the ability of 
these antibodies to influence sperm function. 
The significance of white blood cells in the ejaculate remains a point of further investigation. 
Barratt et al. 11 documented the white blood cell types in the ejaculates of vasovasostomized 
men and noticed that those men without antisperm antibodies had a predominance of suppres-
sor/cytotoxic T cells over helper/inducer T cells. Witkin and Goldstein 12 also viewed the fact 
that a decrease in suppressor/cytotoxic T cells may lead to a condition in which the formation 
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of antisperm antibodies is stimulated. Broderick et al.13 investigated the immunological status 
of 55 patients before and after vasectomy reversal. Those men who had greater quantities of 
sperm-surface antibodies in their vasal fluid had significantly lower motility percentages. 
Spermatic granulomas are thought to have a certain impact on the development of 
immobilizing antibodies. Alexander and Schmidt14 performed a study on 77 vasovasostomized 
men and found more sperm-immobilizing antibodies in patients with granulomas than in those 
without. In the previously mentioned study of Broderick et al.13, only 2 out of 12 patients (with 
significant sperm-surface antibodies) had granulomas. In a review article by Cos et al.15 the 
presence of a sperm granuloma at the site of ligation after vasectomy might be interpreted as a 
pressure relief valve. Those patients, who underwent a reversal procedure, including removal 
of their granulomas before reanastomosis, had an explicit good quality sperm in their 
ejaculum. 
These studies illustrate once more that the opinions on this subject still differ. We maintain our 
policy of performing reversal procedures even in patients with considerably raised preoperative 
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The success of a vasectomy reversal depends on several factors. A well known factor is the 
obstructive interval which is the time period between vasectomy and reversal. Other factors are 
length of the vas resection during vasectomy and occurrence of vasal fluid from the testicular 
end at the time of reversal as well as fertility status of the partner and the partner’s age. In this 
review article we will focus on the influence of sperm granuloma, antisperm antibody 
formation and tissue damage to epididymis and testis on the final outcome of a vasectomy 
reversal. Many studies were contradictory on this subject raising uncertainty on their 
importance. Ligation of the testicular end at the time of vasectomy will lead to an enhancement 
of epididymal pressure sometimes resulting in granuloma formation as well as antisperm 
antibody production. This raise in pressure will eventually lead to tissue damage of epididymis 
and testis. What is the impact of a pressure release valve like a sperm granuloma on this 
sequence and what is the influence of this tissue damage on the vasovasostomy result? Do 
open-end vasectomies at the testicular side prevent these histological alterations and how do 












Role of sperm granuloma  
Sperm granulomas are present in 10-30% of men undergoing a reversal procedure 1. Sperm 
granulomas play an important role in the regulation of chronic obstruction in the male 
reproductive tract. A sperm granuloma is a complex network of multiple minimal epithelialized 
channels that help to prevent high intraluminal pressure in the obstructed ducts. Obstructive 
vasectomy induces a rise in pressure affecting the epididymis and efferent ductules. These 
structures become markedly distended and then adapt to reabsorb large volumes of testicular 
fluids and sperm products. In time all vasectomized men will develop blow outs of the 
epididymis or efferent ducts. Sperm granulomas may develop at the site of the disrupture and 
secondary epididymal or efferent duct obstruction may result. These events are the reason why 
vasectomy reversal is less successful if the obstruction interval increases. Sperm granulomas on 
the other hand may prevent this progressive damage to the epididymis and efferent ducts 
because these granulomas may act as pressure valves protecting the epididymis and efferent 
ducts from further deterioration. Above mentioned processes are extensively described in 
numerous animal studies 2-7. From these studies there is little doubt that epididymal and 
testicular obstruction due to vasectomy will eventually lead to rupturing of epididymal tubules 
and formation of granulomas in these animals. Because it is difficult to obtain human tissue 
specimens there is only limited information on morphologic changes of human testes and 
epididymidis after vasectomy, but spermatic granulomas are reported 8.   
Spermatic granulomas do probably have an impact on the development of immobilizing 
antibodies. Alexander and Schmidt 9 performed a study on 77 vasovasostomized men and 
found more sperm-immobilizing antibodies in patients with granulomas than in those without 
(67% versus 48%). In contrast, in a study performed by Broderick et al.10, only 2 out of 12 
patients with significant sperm-surface antibodies had granulomas. In a review article 11, the 
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presence of a sperm granuloma at the site of ligation after vasectomy might be interpreted as a 
pressure release valve. Those patients, who underwent a reversal procedure, including removal 
of their granulomas before reanastomosis, had an explicit good quality sperm in their 
ejaculum. These findings that men with sperm granuloma at the site of ligation had better 
intraoperative sperm quality and improved patency (81%) and pregnancy rates (53%) were 
previously described by Silber 12,13 . These outcomes were conflicting with the results of the 
Vasovasostomy Study Group 14 who presented the results of 1469 microsurgical vasectomy 
reversals. The presence of bilateral sperm granulomas at the vasectomy sites had no beneficial 
effect on the patency (p=0.050) or pregnancy rates (p=0.150). In a more recent paper by 
Boorjian et al. 15 the role of sperm granulomas on the outcome of 213 vasectomy reversals was 
investigated. They described better patency rates in men with granulomas then in those without 
(95% versus 78%). It is remarkable that there are no more recent literature data (pub med 
search 1998-2005) on the role of sperm granuloma as a possible mediator in successful 
vasectomy reversals. If the presence of sperm granulomas is important for increased success 
rates after vasovasostomy remains a question. 
Could open-ended vasectomies induce sperm granuloma formation at the testicular end and 
could it thus have a beneficial effect on vasectomy reversals as it works as a pressure release 
valve? If so, could open-ended vasectomies be a solution to prevent increased pressure in the 
epididymis and subsequent bursting of epididymal tubules leading to granuloma formation 
within the epididymis and ductul obstruction. Shapiro and Silber 16 studied the development of 
granuloma formation in larger series of patients with open ended vasectomy. In a group of 410 
patients from Ottawa, 97% developed a sperm granuloma at the non-ligated testicular vas end. 
In a second group of 23 patients from St Louis, all patients developed sperm granulomas at the 
testicular end. Despite this possible beneficial granuloma effect, Goldstein 17 stressed the fact 
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that open ended vasectomies could lead to higher vasectomy failure rates and therefore should 
be applied with the utmost precaution. In a larger series by Errey and Edwards 18 this risk of 
spontaneous recanalization was weakened. They compared 4330 open-ended vasectomies with 
3867 standard vasectomies and spontaneous recanalization was rare in both groups. Essential 
was that the abdominal end was covered by vas sheath. All studies 19-23 published in the last 
fifteen years on the subject of open-ended vasectomy indicated reduction of epididymal 
congestion and post vasectomy orchialgia, but none of these studies gave definitive prove of a 
beneficial effect on vasovasostomy results in terms of patency and pregnancy rates. A well 
designed comparative study, between patients who had closed-ended or open-ended 
vasectomies before vasectomy reversal, is mandatory on this subject, taking into account that 
the outcome of vasectomy reversal is multifactorial.  
 
Development of antisperm-antibodies  
Presence of T suppressor/cytotoxic cells and formation of antisperm antibodies  
Vasectomy may also induce local and systemic immune effects. Regarding the local effects, 
chronic epididymal obstruction results from inspissated sperm, damaging the efferent ducts 
leading to leakage, granuloma formation and fibrosis. Intraductal phagocytosis (with 
degradation of sperm) produces soluble antigens that pass the damaged transverse epithelial 
tight junctions due to distension and leakage. Inoculations of the immune system with these 
sperm antigens will result in activation of the humoral immunity system leading to antisperm 
antibody production. Obstructive vasectomy results in such a violation of the blood-testis 
barrier resulting in detectable levels of serum antisperm antibodies in 60-80 percent of men 
after vasectomy. Some data indicate diminishing of antibody titers in serum two or more years 
after vasectomy, others indicate persistent titers 24-27.  
 
 66
Next to the humoral immune system there is a cell mediated immune system. This involves the 
killing of antigens by phagocytes, cytotoxic lymphocytes and natural killer cells. The T cell 
lymphocytes are responsible for cell mediated immunity. After recognizing the antigen, the T 
cell lymphocytes order the B cell lymphocytes to produce antisperm antibodies. There are two 
subtypes of T cells (helper and suppressor) which are of importance in cell mediated immunity 
at the male genital area. The most important are the T suppressor/cytotoxic cells which occur 
mainly at the area of rete testis and efferent tubules. The existence of the T suppressor 
/cytotoxic cells at these locations could, as a theory, suppress any immune reaction and could 
probably play an important role in the prevention of antisperm antibody production 28. In a 
study by Witkin and Goldstein a group of non vasectomized men were compared with men 
who had undergone both a vasectomy and a microsurgical vasovasostomy. Antisperm 
antibodies were detected in sperm, in seminal fluid and/or in serum of all the vasovasostomy 
patients but in none of the controls. Damage to the integrity of the excurrent ducts may induce 
alterations in T cell regulation, leading to a decrease in T suppressor/cytotoxic cells creating 
formation of auto antibodies to sperm-specific antigens 29.  
 
Consequences of antisperm antibodies in semen   
Only few (4%) vasectomized men have antibodies detectable in seminal plasma 30.  
After vasovasostomy sperm agglutinins may appear in the seminal plasma of some men, 
provided that antisperm antibodies were detectable in serum before operation. Thus, 
systemically and/or locally produced antisperm antibodies do enter the obstructed part of the 
male genital tract in vasectomized men. This was confirmed in a study on motile epididymal 
spermatozoa obtained from men during vasovasostomy 31. It was found that the antisperm 
antibodies detected with the mixed antiglobulin reaction (MAR) were bound to the sperm 
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surface at the epididymis level of the male genital tract. One year after operation the MAR-
results on ejaculates were almost identical to the results obtained with epididymal spermatozoa. 
Thus, the binding of antisperm antibodies, takes place primary at the level of the epididymis. A 
study with split ejaculates from different compartments, did not exclude however, that 
additional binding may take place at the level of the prostate and the seminal vesicles 32. 
Linnet et.al. 33 pointed out the significance of antisperm antibodies for pregnancy rates. They 
found a pregnancy rate of 85% among vasovasostomized men without antisperm antibodies in 
seminal plasma; however the mere presence of antisperm antibodies in seminal fluid, using the 
tray agglutination test (TAT), reduced the pregnancy rate to 14%. These results were confirmed 
by several other studies on this subject. Parslow et.al 34 found that the presence of  antisperm 
antibodies in seminal plasma after vasectomy reversal was associated with diminished fertility 
only if the titer in the TAT exceeded 16, nevertheless even with higher titers, conceptions 
occurred. Studying serum antisperm antibodies, the same group 35 observed that pregnancy was 
significantly less likely when the preoperative serum antisperm antibody titer in the TAT was 
high, 512 or more. 
Matson and co-workers 36 found reduced conception rates in those couples in whom the 
presence of IgG or IgA+IgG antisperm antibodies occurred in seminal fluid. Meinertz et al. 37 
reported on 216 vasovasostomized men who were tested with the mixed antiglobulin reaction 
for IgA, IgG and secretory IgA antisperm antibodies bound to the sperm membrane. Free 
antisperm antibodies were analyzed with the gelatine agglutination test and the TAT. In a 
subgroup with only IgG response, the rate of conception was 85.7%, while 42.9% of men, who 
also had IgA on the sperm, achieved pregnancy. When 100% of the sperm was covered with 
IgA, the conception rate decreased to 21.7%. The combination of IgA on all sperm and a serum 
titer ≥ 256 was associated with zero conception. Aitken et al. 38 described the impact of 
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antibodies to stimulate or suppress sperm/oocyte fusion. In vasovasostomized patients they saw 
a higher stimulating effect on this fusion than in patients with primary infertility. In their series 
they observed no correlation between the antisperm antibodies titers in serum and seminal 
plasma and the ability of these antibodies to influence sperm function.  
The significance of white blood cells in the ejaculate after vasovasostomy remains a point of 
further investigation. Barratt et al. 39 documented the white blood cell types in the ejaculates of 
vasovasostomized men and noticed that those men without antisperm antibodies had a 
predominance of suppressor/cytotoxic T cells over helper/inducer T cells. As previously said, 
Witkin and Goldstein 29 also viewed the fact that a decrease in suppressor/cytotoxic T cells 
may lead to a condition in which the formation of antisperm antibodies is stimulated.  
 
Histological changes of testis and epididymis after vasectomy and vasectomy reversal 
Animal studies 
Postvasectomy histological changes in rats were discussed by Turner et al. 40 who described the 
importance of certain proteins in testis and epididymis (cysteine-rich secretory protein, 
prostaglandin D2 synthetase, phosphatidylethanolamine-binding protein) in the maturation and 
possible agglutination of sperm cells after vasovasostomy. The interstitial tissue in the 
epididymis was much more densely occupied by lymfocytic cells than in sham operated 
controls, suggesting that sperm material might have escaped the lumen, provoking an 
inflammatory reaction.  
The relationship between development of antisperm antibodies after unilateral vasectomy and 
the occurrence of testicular damage on the non-vasectomized side was studied by Chehval et al. 
41. They performed a unilateral vasectomy in rats and described a relationship between the 
onset of antisperm antibodies after 30 days of obstruction and the occurrence of testicular 
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changes on the contra lateral side. They concluded that epididymal and/or testicular tissue 
damage after vasectomy does not only depend on high pressure in the epididymis but also on 
deposition of systemic circulating immune complexes as seen in the healthy non-obstructed 
side.  
Johnson and Howards 42 investigated the effect of increased intraluminal pressure in the testis 
and epididymis after vasectomy in hamsters. They described mainly an increase in pressure in 
the epididymis and not in the testis. The pressures measured in the cauda epididymis, two 
weeks after vasectomy, were significantly higher (p<0.0005) compared to normal controls. Due 
to distension of the epididymis, ruptures were seen, illustrating the limitation in distensibility of 
the epididymis and its reabsorptive capacity. They could not find change in weight of the testes 
compared to normals four weeks after vasectomy. The effect of vasectomy on the epididymis in 
rats was also extensively studied by Flickinger et.al. 3. Increased pressure in the epididymis is 
not generally transmitted towards the seminiferous tubules. The epididymal interstitium shows 
microscopic changes indicative of chronic inflammation with infiltration of lymphocytes, 
macrophages and plasma cells. Rats that have these tissue changes also have higher antisperm 
antibodies in serum. Due to these pressures the epididymal ducts will burst with escape of 
spermatozoa leading to an immune response and granuloma formation. 
Whether testicular alterations after vasectomy are reversible by vasovasostomy was studied by 
Flickinger et.al. 43. A group of Lewis rats was vasectomized and testicular weight and 
morphological alterations were described. Especially as time after vasectomy went by the 
testicular alterations enhanced. As a vasovasostomy procedure was advanced, the progression 
of these testicular changes was reduced but not reversed. Smaller testicles after vasectomy 
showed severe alterations in the seminiferous tubules compared to heavier testicles that 
presented with a normal morphology. Testicular alterations were graded for light microscopy 
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by use of a semiquantitative testicular biopsy score count (TBSC). As a result, the degree of 
morphologic changes corresponded closely to the testicular weight. A similar study in Lewis 
rats was performed by Herr et al. 44. Testicular weight, histology and antisperm antibodies were 
studied, using enzyme-linked immunosorbent assay (ELISA). Animals with altered testes after 
vasectomy showed significantly greater mean absorbance values in ELISA, compared to 
animals without testicular alterations. Animals with a positive antisperm antibody response 
were seen in the group with testicular alterations but also in the group without testicular 
damage. Compared to the sham group, the level of antisperm antibodies in the vasectomized 
and vasovasostomized animals was significantly higher. Animals that had a successful reversal 
procedure (in terms of sperm count) showed even after 4 months similar elevated 
concentrations of antisperm antibodies compared to the vasectomized rats. The group of 
animals with small testes after vasectomy showed severe microscopic alterations consisting of 
depletion of germ cells. Seminiferous tubules lacked all stages of germ cells and thus were 
composed almost entirely of Sertoli cells. Animals with normal sized testes showed no 
morphological changes and resembled those of the sham group. These findings were confirmed 
by Neaves 45, who also examined histological changes on the testes in rats after vasectomy.  
Vasovasostomy results, in terms of semen quality, were significantly better in animals that had 
a vasocystostomy as a contraceptive method compared to animals that had a vasectomy (100% 
versus 36 %). This is due to the epididymal and testicular changes after vasectomy. In 19 out of 
26 rabbits (73%) some degree of disruption of the germinal epithelium of the testis was seen, 
however no testicular alterations were seen in the vasocystostomy group. Also the epididymis 
of vasectomized rabbits showed significant tissue changes in 42%. Especially fibrosis was seen 
in the caput and corpus area. In the vasocystostomy group only one granuloma was seen in the 
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cauda epididymis. Pressure release thanks to the vasocystostomy was of importance in the 
prevention of epididymal and testicular tissue damage 46.  
 
Human studies 
Studies on the effect of interstitial testicular fibrosis on vasovasostomy results in men are 
sparse. Jarow et al. 47 took testis biopsies from men undergoing vasectomy reversal and healthy 
volunteers. The morphometric analyses of these specimens revealed a significant increase in 
thickness of seminiferous tubular walls mean cross-sectional tubular area and a reduction in the 
mean number of Sertoli cells and spermatids. Focal interstitial fibrosis was only seen in the 
vasectomy group and not in the controls. They observed a significant (p<0.01) correlation 
between interstitial fibrosis and successful vasectomy reversal. In continuation of this study, 
Jarow et al. 48 pointed out that there was no association between testicular histologic changes 
and immune status of vasectomized men.  
In two more or less identical studies by Shiraishi et al. 49,50 men obtained a testis biopsy at the 
time of vasectomy reversal. Significant increase in interstitial fibrosis was seen as obstructive 
intervals became longer. Interstitial fibrosis and not the extent of germ cell differentiation, 
measured by the proliferative cell nuclear antigen expression (PCNA), were important in the 
successful outcome of the vasectomy reversal. In a recent study by Raleigh et al. 51 34 men 
receiving testicular biopsies at the time of vasectomy reversal were compared with 10 normal 
controls. Biopsies were examined for testicular germ cell populations and testicular fibrosis. 
Patients undergoing a vasectomy reversal had a significant decrease in germ cells in the later 
stages of spermatogenesis and had a significant increase (2.7 fold) in interstitial fibrosis. Both 
changes correlated strongly with the obstructive interval and the final outcome of the 
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vasectomy reversal. From these studies it seems obvious that testicular change do occur after 
vasectomy and that these changes do have an influence on the outcome of vasectomy reversal.  
 
Discussion  
Sperm granulomas, antisperm antibodies and tissue damage to epididymis and/or testis after 
vasectomy are all related to one another.  Nevertheless each anomaly itself has a certain impact 
on the results of vasectomy reversal.  
Regarding the literature, sperm granuloma will develop eventually in all men who had a 
vasectomy. From animal studies it is clear that sperm granulomas act as pressure relieve valves 
preventing further tissue damage to epididymis and testis. Otherwise the appearance of sperm 
granuloma induces the production of antisperm antibodies that still might damage the 
epididymal and testicular tissues. No study in men has been published with prove that the 
existence of sperm granuloma do improve vasovasostomy results. Several studies on the 
subject of open-ended vasectomies look promising on the reduction of epididymal pressure rise 
preventing damage to the ductules and thus antisperm antibody formation.  
Concerning antisperm antibodies, a strong relationship between the appearance of sperm 
granuloma and antisperm antibodies is apparent. The importance of these antisperm antibodies 
in vasectomy reversal remains unclear. It is clear from studies published in literature, that 
higher antisperm antibodies titers in serum before vasectomy reversal do have an adverse effect 
on sperm quality. It is obvious that antisperm antibodies in serum do not influence the sperm 
motility. It is the antibodies in seminal plasma that interfere with sperm motility. Measuring of 
antisperm antibody titers in serum does not automatically indicate that ‘immobilizing antisperm 
antibodies’ are present in semen. Unfortunately we can not determine the influence of 
antisperm antibodies on sperm as long as the patient is still in a vasectomy status.  
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When considering vasectomy reversal, the relevance of these antisperm antibodies in daily 
practice is still unclear. Do higher antisperm antibody titers restrain physicians from 
performing a reversal procedure? We think not, because the only alternative is assisted 
reproductive techniques (ART).  This alternative treatment is invasive for wife and man and 
much more expensive 52,53.  
From animal studies we know that tissue damage is mainly occurring in the epididymis due to 
tubular rupturing, fibrosis and eventually obstruction. The testis is not always protected from 
these increased pressures. Interstitial fibrosis and increased seminiferous wall thickness are the 
most frequently described changes in testicular parenchyma in men. Despite the fact that the 
numbers of studies (and patients in these studies) are limited, we are convinced that testicular 
damage eventually occurs. With longer obstructive intervals more damage to the tissues will be 
seen, with an adverse effect on patency and pregnancy rates. But then again, who takes testis 
biopsies before vasectomy reversal and measures the amount of interstitial fibrosis and germ 
cell differentiation? Our knowledge of the influence of tissue changes in the testis on the 
outcome of vasectomy reversal is still limited. The importance of these tissue changes in men 
remains unclear due to the fact that from an ethical point of view these studies are hard to 
perform. 
Reviewing the literature, some form of pressure release of the epididymis after vasectomy will 
have a beneficial effect on vasovasostomy results. The fear that open ended vasectomy results 
in a higher failure rate (in terms of azoospermia) seems not justified. If so, open-ended 
vasectomy could be the technique of choice in an era with growing numbers of divorces and 
renewed wish to have a child. But how can we be sure that if we leave the testicular end open 
that reactive fibrosis will not completely occlude this testicular end? How can we investigate 
the development of a possible sperm granuloma at this end and how can we be sure that this 
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works as a pressure relieve valve? A comparative study between open-ended and closed-ended 
vasectomy has to be performed to prove this hypothetical beneficial effect of open-ended 
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Vasectomy has become widely accepted as a safe and reliable method for contraception1-3. 
Worldwide, more than 40 million couples rely on vasectomy to prevent pregnancy. The 
procedure is fast and reliable, and the long-term complication rates are low, i.e., in the range 
0.08 – 0.10 %. The popularity of vasectomy has induced, however, an increasing demand for its 
reversal operation, which is known as vasovasostomy. In essence, vasovasostomy is bilateral 
microsurgical rejoining of the loose ends of the vas deferens. A recent population-based study 
by Holman et al. 4, which was performed on a large cohort of vasectomy patients (>28,000) in 
Western Australia, showed that the population rates of vasectomy are stable, while the 
incidence of seeking a reversal has increased. The most important factors are:  age, being 
single, being divorced, and being separated. Age appears to be an important factor: for men 
who had the vasectomy between 20 and 24 years of age, it was found that 11 % seek reversal 
within the first 15 years. For the cohort 25 – 29 years, this percentage was 6 4. 
Compared to vasectomy, vasovasostomy is a technically demanding operation. Modern 
microsurgical techniques, pioneered by Silber, represent the golden standard 5,6. From 
literature, it can be concluded that the rates for patency and maternity are in the range 85–90 %  
and 50–60 %, respectively. Scarification and stricturing are believed to be the major causes of 
failure. According to Silber’s original concept, the anatomoses are made in two layers. Some 
urologists prefer a modified one-layer technique, which is easier to perform, quicker, and 
believed to induce less scarification and stricturing. Fischer and Grandmyre compared the two 
techniques, and found that the patency rates are comparable 7 . However, the mean operation 
time was 167 min for the two-layer technique, and 96 min for the modified one-layer 
procedure. There have been several attempts to improve the technique for vasovasostomy 
further. For example, Seaman reported preliminary experiments with a laser technique to 
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facilitate vasovasostomy surgery 8, and Rothman et al. described a clinical trial with an 
absorbable polymeric stent for vasectomy reversal 9. The absorbable stent, however, resulted in 
lower patency rates (81 % vs. 90 %), and lower pregnancy rates (22 % vs. 51 %), as compared 
to two-layer microscopic vasovasostomy.  
Herein, we report our first experience with a new vasovasostomy technique, which is based on 
the use of a non-absorbable polymeric hollow mini-stent. This device is implanted to keep both 
vas deferens lumens open and exactly in line. We postulated that use of the ministent will 
decrease the risk for scarification and stricturing, provided that the biomaterial is sufficiently 
biocompatible. Furthermore, it was anticipated that the mini-stent will facilitate the operation. 
Biodegradability was considered to be of minor importance.  
At the onset of this study, we decided to use a biomaterial on the basis of NVP. Poly (NVP) is 
well-known for its excellent biocompatibility and safety. For example, NVP-containing 
copolymers were found to adhere to porcine intestine to create a hydrophilic surface for cell 
adhesion and growth. As in our previous work10, we copolymerized NVP with n-
butylmethacrylate (BMA) 11,12. These copolymers do not dissolve in water, and the NVP/BMA 
ratio provides a means to control the hydrophilicity and the degree of swelling. Furthermore, 
the material was cross linked by incorporating tri (ethyleneglycol) dimethacrylate in the 
reaction mixture. The exact composition was chosen on the basis of two criteria and a series of 
preliminary experiments. The criteria were: 
* The material must have sufficient rigidity in the dry state to allow for precision 
machining. 
* Immersion in water must lead to considerable softening, keeping the dimensions 









Fig 1. Design of the polymeric mini-stent. a, Computer-generated picture, showing the tapered ends and the 
ridge in the middle of the mini-stent. The ridge is sandwiched between both ends of the vas deferens, thus 
preventing migration of the mini-stent. b, Exact geometry  (millimetres).    
 
 
We postulated that the phenomenon of softening and swelling could be utilized, 
especially to facilitate implantation of the mini-stent. A procedure consisting of three 
steps was developed: 
* First, one half of the mini-stent is carefully inserted into the lumen of the vas 
deferens, i.e, till the end of the vas reaches the ridge. The rigidity of the biomaterial is 
advantageous for this step; softening of the stent-half starts after its positioning in the 
vas lumen. 
* Secondly, the other stent half is inserted into the lumen of the other vas end. Again, 
this is facilitated by the hardness of the dry stent-half. It is essential to perform this 
step immediately after the first one, in order to avoid premature softening. 
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* Thirdly, sutures are placed, such that the ridge is sandwiched between both vas ends. 
The third step should be performed 2 - 3 minutes later than the second one, to enable 
softening of the ridge prior to suturing. 
We verified, in a small number of ex vivo pilots that preceded the animal experiments, 
that this three-step implantation technique is feasible in practice. Vas material from both 
rabbit and human origin was used in these pilots; size and structure of human and rabbit 
vas deferens are highly comparable. 
 
Materials and Methods 
Polymere synthesis and mini-stent manufacture.  
All reactive monomers were purchased from Aldrich, and were purified by distillation in 
vacuo. 1-Vinyl-2-pyrrolidinone (25.83 g, or 232.4 mmol), n-butyl methacrylate (14.22 g, or 
100.0 mmol), and tri(ethyleneglycol) dimethacrylate (191 mg, or 666 µmol) were transferred 
into a 100-mL round bottom flask. The radical initiator 2, 2’-azobis (2-methylpropionitrile) 
(AIBN, 24.0 mg, or 146 µmol) was added and the contents of the flask were thoroughly mixed. 
The reaction mixture was transferred into several Teflon® tubes, and the polymerization was 
executed as described 11. The polymerization reaction proceeded smoothly and reproducibly. A 
specimen of the material (weight: 0.86 g) was incubated in distilled water (25 mL, 25 oC) for a 
period of 1 week. Water uptake and swelling were observed during the first 12 h; no further 
changes occurred afterwards. After the week of incubation, the aqueous medium was separated 
and lyophilized. The residue was dissolved in 1 mL of D2O, and subjected to analysis by 1H 
NMR spectroscopy at 400 MHz. Only a trace of residual NVP was detected; back-calculation 
revealed that the original sample contained less than 10 mg of NVP, which is approximately 1 
% of the monomer that was present originally. It was established in a separate control 
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experiment that no free NVP evaporates during lyophilization. A conversion rate of 
approximately 99 % is not exceptional for laboratory-scale bulk polymerizations. The 
biomaterial was obtained as cylindrical rods, which were slightly opaque. The rods were cut in 
pieces of approximately 20-mm length, which were machined on a computer-controlled 
lathe/mill system (Boley, Eslingen, Germany; type: BDN 160 R).  A 1.00-mm hole was first 
drilled along the cylindrical axis of the specimen. A straight steel wire was fitted into the hole, 
to reinforce the delicate material during machining toward the desired shape.  
 
Animal experiments.  
All animal experiments were done according to the Principles of Laboratory Animals Care 
[prepared by the National Institutes of Health (NIH Pub. No. 85-23 rev. 1995]. The study was 
approved by the Animal Experimental Committee of the University of Maastricht. All animals 
were male New Zealand white rabbits, aged between 6 and 12 months at the start of the 
experiments. Animals were anesthetized through intramuscular injection of ketamine (0.5 
mL/kg) and xylazine (0.5 mL/kg). During the operation, a mixture of ketamine and xylazine (2 
: 1) was administered intravascularly at a rate of 0.2 mL per 30 min. Animals were placed in a 
dorsal position, shaved, and sterilized. A transverse skin incision was made over both spermatic 
funiculi. The spermatic internal fascia was opened, and the vas deferens, lying loose within the 
funiculus, was easily luxated leaving the scrotal contents in situ. The vas was cut in a transverse 
way, and reconstructed immediately. Mini-stents were implanted bilaterally in the first group, 
after which both vas ends were approximated with three sutures of one-layer Prolene® 8.0 
overlying the stent (a microscope was used). The second group underwent microscopical 
reconstruction with 4 to 5 one-layer Prolene® 8.0 sutures. For both groups, the vas was 
replaced within its funiculis and the spermatic internal fascia and overlying skin were closed 
 
 87
with 4.0 Vicryl®. Postoperatively, the animals received Temgesic (0.1 mL/kg) for a maximum 
of 48 h.  
Semen samples were collected several days before the operation, and at regular time intervals 
after the operation, vide infra. The samples were obtained with the help of an artificial vagina 
system, as is normally used in agricultural artificial insemination stations for rabbits. At the 
time of sacrifice, the animals were deeply anesthetised, and then euthanised by an overdose 
injection of pentobarbital. Explanted vas deferens specimens (with or without mini-stent) were 
subjected to standard histopathological analysis (light microscopy, staining with hematoxylin 
and eosin). 
 
Results and Discussion 
Thirthy-two male rabbits were included. First, semen analyses of all animals were 
performed; bundant numbers of sperm cells were found in almost every case (Tables 1 
and 2). Vasectomy was performed on a small control group of 4 rabbits, with the aim to 
determine how much time is needed to obtain azoospermia. To the best of our 
knowledge, this information is not available in the literature. Semen analyses after 6 
weeks and after 3 months showed complete azoospermia in all four cases. The four 
animals were then sacrificed. The remaining 28 rabbits were randomized over two equal 
groups. The first group underwent vasovasostomy with the mini-stent. One animal in this 
group died unexpectedly, soon after the operation, because of a gastric hair-ball. The 
second group underwent conventional vasovasostomy, i.e. using one-layer microscopic 
surgery. We also lost one animal in this group, because of pneumonia. At least 4 post-
operative semen analyses were performed for each animal; in each case the last sample 
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was obtained just prior to sacrifice and autopsy. The results of these analyses are 
compiled in Tables 1 and 2.  
 
 
Table 1. Sperm cell concentrations measured for the rabbits with two implanted mini-stents. 
 




analysis at weeks 
Mean number of sperm 





per mL  
(millions) 
                                      Mini-Stent Group 
1 160 4, 6, 9, 12 115 209 
2 107 2, 4, 10, 13 403 710 
3 1400 8, 12, 16 445 871 
4 316 7, 13, 25, 37, 42 774 770 
5 261 7, 17, 31, 36, 41 454 520 
6 205 7, 17, 17, 31, 36, 41 540 1268 
7 300 14, 31, 33, 38, 41 439 375 
8 54 7, 22, 28, 31, 33 361 423 
9 755 17, 24, 27, 28 663 425 
10 845 17, 24, 27, 29 505 690 
11 193 13, 23, 26, 28 395 371 
12 125 13, 23, 26, 28 327 187 
13 980 11, 21, 25, 26 569 76 
Average 439 - 461 530 




Table 2. Sperm cell concentrations measured for the rabbits in the control group, on which conventional 
 end-to-end vasovasostomy was performed.  
 




analysis at weeks 
Mean number of sperm 
cells per mL, post- 
operative (millions) 
Final number of 
sperm cells per 
mL  (millions) 
                                            End-to-end Group 
1 850 8, 14, 26, 38, 42 410 651 
2 760 8, 14, 26, 38, 42, 44 300 233 
3 324 7, 13, 25, 37, 41 312 360 
4 785 7, 13, 26, 37, 42 651 960 
5 414 7, 23, 37, 42, 47 531 258 
6 625 7, 13, 25, 37 570 570 
7 766 13, 30, 37, 40 437 450 
8 249 13, 31, 37, 40 380 439 
9 889 16, 23, 26, 28 420 620 
10 324 16, 23, 26, 28 641 520 
11 477 15, 22, 26, 29, 30 441 1267 
12 283 15, 25, 28, 30 270 215 
13 325 15, 22, 28, 40 492 430 
Average 544 - 450 536 




The mini-stent remained patent in all 13 cases (Table 1). There was generally a high 
concentration of living sperm cells in the semen samples which were taken prior to autopsy. 
Preoperatively, the average sperm cell concentration in this group was 439 million / mL with 
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a very high spread (s.d. = 418 million / mL). Prior to autopsy, this average was 530 million / 
mL (s.d. = 326 million / mL). Using the Student’s t-test (two-tailed distribution, paired), it 
followed that p = 0.525, i.e. the sperm counts in the two series are not significantly different. 
Histopathology of the explants showed that mini-stent is well-tolerated in the rabbit vas 
deferens. Signs of a mild inflammatory response were usually seen in the surrounding tissue. 
Most likely, this is a normal reaction to the presence of a foreign polymeric biomaterial. 
Remarkably, the epithelium that constitutes the highly curved lumen of the normal vas 
deferens, adapts to the presence of the mini-stent (Figure 2). None of the implants were 
surrounded by a fibrous capsule. In many cases, sperm cells were observed inside the lumen 
of the mini-stent (Figure 2d). Rabbit # 13 was matched with a female partner, in order to 
establish whether the mini-stent allows actual propagation. The female became pregnant, 

























Fig  2  Histology of the vas deferens explants (light microscopy, staining with haematoxylin and eosin). 
a, b, Normal rabbit vas deferens (transverse view at two different enlargements), showing the pronounced 
curvature of the epithelium. All cell nuclei, especially those of the smooth muscle cells in the outer layers 
of the vas deferens, are clearly visible. c, Transverse view of a representative explant that contains a mini-
stent. This section was cut in the central part; note that the epithelium lies as a circular band adjacent to 
the exterior surface of the mini-stent. d, View as in c, but now cut close to the proximal end. Here, the vas 
lumen is wider than the stent, thus leaving an interstitial space around the stent. Spermatozoa were 
observed in the lumen of the mini-stent, as well as in the interstitial space 
 
The data in Table 2 show that all end-to-end operations were also successful. In this 
group, the average sperm cell concentration prior to the operation was 544 million / mL 
(s.d. = 241 million / mL). Prior to the different autopsies this average was 536 million / 
mL (s.d. = 298 million / mL). These data reflect that conventional end-to-end 
vasovasostomy is a well-established technique. The operation is associated with a very 
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high rate of success, provided that the skilled surgeon can work in a suitable 
infrastructure and with adequate equipment.  
Both methods led to 100 % patency, and the ultimate sperm counts were generally very 
high. Using the Student’s t-test (two-tailed distribution, paired) to compare the arrays of 
sperm counts (prior to autopsy) for two groups, a p-value of 0.961 was found. This 
indicates that the outcome of both groups is not statistically different at all.  
It was experienced that vasovasostomy with use of the mini-stent was faster and easier to 
perform. The data in Table 3 show that the bilateral operation is accelerated by 
approximately 30 min, due to the use of the mini-stent. For the mini-stent group, an 
average operation time of 98 min was found (s.d. = 16 min). For the end-to-end group, 
this average was 132 min (s.d. = 19 min). Based on the Student’s t-test (two-tailed 
distribution, paired), it can be concluded that the operation times for the two groups are 














Table 3. Operation times measured during the vasovasostomy operations of this study.   
 
End-to-end group Mini-stent group 
Rabbit number Operation time 
(min) 
Rabbit number Operation time 
(min) 
1 142 7 98 
2 148 8 92 
3 131 9 110 
10 168 11 111 
13 123 12 62 
14 131 15 111 
16 142 17 75 
21 139 18 83 
23 111 25 105 
24 99 26 113 
29 121 27 98 
30 149 28 107 
31 112 32 109 
    
Average 132 - 98 







The patency rate for microsurgical vasovasostomy in humans is approximately  85-90 % 
4,13,14. Most probably, the higher patency rates in our model can be ascribed to the fact 
that the rejoining of the vas deferens was performed immediately after dissectioning; the 
time interval between vasectomy and vasovasostomy in clinical practice is usually in the 
order of several years.  
Recently, it has become clear that vasovasostomy is the therapy of choice for obstructive 
azoospermia after vasectomy 15. Kolettis et al. showed that the cost per living birth after 
vasovasostomy is approximately 31,000 US $, while the cost per living birth after 
epididymal sperm aspiration / intracytoplasmic sperm injection is around 51,000 US $ 16. 
More recently, Heidenreich et al. also concluded that vasovasostomy is preferred over its 
alternatives 17,18.  Our next step is to investigate the utility of the mini-stent in humans. 
The two questions to be answered are, evidently:  
1. Is implantation of the mini-stent in humans as successful as conventional 
vasovasostomy, in terms of short-term and long-term complication rates? 
2. Is the use of the mini-stent cost-effective because of shorter operation time?  
Moreover, the mini-stent may provide an alternative option in those cases where 
conventional vasovasostomy has failed, e.g. as a result of stricturing at the anastomosis. 
The mini-stent may also offer new possibilities to execute vasovasostomies under less 





This animal study indicates that the vasovasostomy operation can be simplified and 
accelerated by using a polymeric hollow mini-stent. From the perspective of biomaterials 
science, it is encouraging that the novel NVP-based hydrophilic biomaterial can, 
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Introduction 
The mean operation time for a bilateral microscopical procedure is 2 hours and 30 minutes 1.  
It is generally accepted that the microscopical reconstruction leads to better patency- and  
pregnancy rates than the macroscopical procedure 2-4. We use a one-layer anastomosis because 
the duration of surgery would be considerably less than a two-layer anastomosis and according 
to several authors a two-layer anastomosis has little if any additional benefit over a one-layer 
anastomosis 5,6.  
Apart from the technical aspects of the procedure, obstruction interval between vasectomy and  
reversal, and the presence of antisperm antibodies, determine the patency and pregnancy rates 7-
12. Technical failure of human vas deferens reconstruction mainly occurs several weeks to 
months after surgery usually as a result of stricturing of the anastomosis. These strictures occur 
because of granuloma formation, and traction on or devascularization of the vas wall, which 
eventually leads to sperm leakage. Absorbable hollow stents have been used to simplify the 
procedure and prevent this sperm leakage. By preventing sperm extravasation, there is less 
perivasal inflammation, reducing secondary stricturing at the site of the anastomosis.  Despite 
contradictory published results, absorbable stents might have the disadvantage of migrating 
easily and absorbing rapidly (10-14 days), leading to early denudation of the anastomosis, with 
possible stricturing. Non-absorbable hollow stents made of inert biomaterial, with a design that 
prevents migration, might improve patency rates by providing a permanent open lumen at the 
site of the anastomosis.  
To reduce the operative duration and to improve patency rates, we developed an “easy to 
perform technique” with a newly-designed hollow nonabsorbable polymeric stent.  This 
hydrophilic stent, with auto-dilating capacity, could help to prevent secondary stricturing of the 
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anastomotic area. The present randomized comparative study between stent and conventional 
microscopic reconstruction was designed to study the effects of both reconstructive techniques 
on the anastomosis area and semen quality, so the transected vas deferens was immediately 
repaired. This eliminated the influence of obstruction time resulting from vasectomy. Thus the 
purpose of this study was to investigate the use of a newly designed nonabsorbable polymeric 
stent in the reconstruction of the vas deferens, comparing it to the conventional microscopic 
reconstruction in a randomized study in rabbits. 
 
Materials and methods 
New Zealand White rabbits (32) were used, the experiments being conducted according to the 
Principles of Laboratory Animals Care (prepared by the National Institutes of Health, NIH Pub. 
No. 85-23 rev. 1995). Anaesthesia was induced by an intramuscular injection with ketamine 
0.5ml/kg and xylazine 0.5 ml/kg, and maintained by an intravenous mixture of 
ketamine/xylazine (2:1, 0.2ml/30min) during surgery. The rabbit was placed supine and a 
transverse skin incision made over both spermatic funiculi. The spermatic internal fascia was 
opened and the vas deferens, lying loose and next to the funiculus, was easily luxated, leaving 
the scrotal contents in situ. The vas deferens was cut transversely and reconstructed 
immediately. The rabbits were randomized either to microscopic reconstruction with four or 
five one-layer 8/0 nonabsorbable polypropylene sutures (Prolene, Ethicon Inc.,Somerville, NJ) 
or had stents placed bilaterally, after which both ends of the vas deferens were approximated 
with three 8/0 Prolene sutures, overlying the stent. Water tightness was checked in both 
procedures by milking sufficient epididymal contents towards the anastomosis area. The vas 
deferens was repositioned, and the fascia and overlying skin closed with 4/0 synthetic 
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absorbable polyglactin suture.After surgery the rabbits received narcotic analgesia (temgesic 
0.1 ml/kg) for up to 48 hours.  
Semen was obtained before surgery to establish the presence of sperm, and at regular intervals 
(2-47 weeks) after surgery; at least four semen samples were taken from each rabbit. The 
semen was collected with an artificial vagina system normally used in agricultural artificial 
insemination for rabbits.  The sperm characteristics consisted of total sperm count, mean 
motility and progressive motile sperm density (PMSD). After the final semen analysis, the 
rabbits were killed and patency assessed histologically at the site of the anastomosis. 
In the dry state the stent has some stiffness that facilitates its placement. Shortly after 
introduction, the stent starts to absorb seminal and serous fluids, which alter the mechanical 
characteristics and make the stent more flexible and elastic. The construction material of the 
stent was N-vinylpyrrolidone and n-butylmethacrylate, and the bifunctional  
cross-linking agent was tetraethyleneglycol dimethacrylate. These reactive substances were  
polymerised using 2,2́ –azobisisobutyronitrile as the radical initiator. Thus the stent comprises a 
hydrophylic biocompatible material containing a hydrophilic and a hydrophobic component, at 
a molarratio of 2:3. The hydrophilic component provides the rubbery characteristics of the 
material after insertion into the vas deferens. To facilitate the rejoining of the two loose ends of 
the vas deferens over the stent, a specific shape of the stent was developed. The stent is a 
hollow tube which is conical at both ends, facilitating insertion in the vas deferens ends. The 
total length of the stent is 8.2mm. The outside diameter, at the site of the central ridge is 1.6mm 
and the internal diameter is 0.6mm. This ridge, in the middle of the stent, prevents the stent 





Fig 1. Configuration and dimensions of the polymeric stent 
 
Results 
Four rabbits had a vasectomy to evaluate the mean time needed to gain azoospermia in case a 
reconstruction would lead to a total obstruction. Before sterilization, semen was analysed to 
establish the presence of sperm in all four rabbits. The semen analysis was repeated after 6-7 
weeks and 3 months; all four rabbits were azoospermic at the first semencontrol and remained 
azoospermic during follow-up; the rabbits were then killed.  
In all, 28 rabbits were used to compare the conventional microscopic reconstructive  procedure 
(“conventional group”) and vasovasostomy using the biocompatible hollow stent (“stent 
group”). Two rabbits died soon after surgery (pneumonia and gastric hair ball), one in the stent 
group and the other in the conventional group, so only 26 rabbits (13 stents and 13 
conventional) were evaluable. The 26 rabbits provided 141 semen specimens; 26 before 
surgery and 115 after surgery.To establish whether the polymeric stent allows actual 
propagation, one rabbit was matched with a female, and after 4 weeks of pregnancy, eight 
healthy young rabbits were born.  
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Total sperm count (or concentration): 
The total sperm counts before surgery (table1) did not differ significantly between groups 
(P=0.08, Mann-Whitney U-test). After surgery, there was a significant difference between 
conventional and stented rabbits in the increased concentrations during the follow-up (P=0.050, 
linear regression analysis with random effects); the total sperm count increased in both 
treatment groups, but more in the stent group (fig.2 ). The mean sperm counts during follow-up 




Table1. Sperm analyses before and after conventional one-layer microscopic reconstructions and stented 
reconstructions of the vas deferens in rabbits 
 
Variable    Stent     Conventional 
Mean (median,range) [SD] 
Before surgery 
Total sperm count, millions/ml              439 (261, 54-1400) [418]           544 (477,249-88900 [240.6] 
Motility %        75 (80, 50-950 [12.9]         68 (75, 20-900 [18.4] 
PMSD, millions/ml                164 (81, 0-560) [193.4]    212 (164, 0-556) [180.7] 
After surgery 
Total sperm count, millions/ml      459 (445, 114.8-776) [163.9]               450 (437, 270.3-651) [122.8] 
Motility %                    25 (32, 0.2-51) [18.6]       40 (43, 2.7-70) [17.9] 








The motility measurements before surgery (table 1) did not differ significantly between both 
groups (P=0.29, Mann-Whitney U- test). After  surgery (table 1), motility decreased during the 
first 0-12 weeks in both groups (P<0.001), but increased significantly thereafter (P=0.002). 
There was no significant difference between groups (fig.2B) in this decrease or increase in the 
course of motility (P=0.11, non-linear regression with random effects). 
 
Progressive motile sperm density (PMSD): 
The PMSD before surgery (table 1) did not differ significantly between groups (p=0.45, Mann-
Whitney U-test);  after surgery, the  PMSD decreased initially (p=0.002) followed by a slight 
but insignificant increase (p=0.061). There was no significant difference between conventional 
and stented rabbits (fig. 2C) in this decrease/increase (p=0.71, non-linear regression with 




























































Fig 2. The available A, sperm counts; B, motility results; and C, PMSD results after surgery. The red (stented 
group) and green (conventional group) lines are regression lines with follow-up time, estimated using random-
effect linear regression analysis to account for the correlation between repeated measures in the same animal. In 
























































All conventional and stented reconstructed vasovasostomies, were evaluated histologically. 
Histological sections in the stented group were taken at a mean (range) of 41 (39-44 ) weeks 
after the initial operation,  vs 42 (40-47) weeks in the conventional group. 
In five of 13 conventional reconstructed vasa deferentia there was partial obstruction  
(>50% narrowing of the original lumen diameter) but with sufficient patency. In the stented 
group there was no partial or complete obstruction. In all 13 stented rabbits there was flattening 
and atrophic changes of the epithelium of the vas deferens wall, and eosinofilic inflammatory 
reaction (fig.3). The atrophy was probably a result of the pressure of the stent wall against the 
vas deferens wall.  All the proximal and distal transverse luminal sections contained sperm 
cells, showing good patency.    
 
Operation time: 
The mean (range) operative duration was 132 (99-168) min in the conventional and 98 (62-113) 
























Fig 3.  Hematoxylin and eosin-stained transverse sections of rabbit vas deferens in various presentations. A, 
section of a normal vas deferens with wide lumen, containing sperm in the centre. B, severe stenosis after a 
conventional (end-to-end) sutured microscopic reconstruction, note 8/0 Prolene sututres running through 









Temporary exteriorized stents 
Most previous studies on exteriorized stents used a temporary stent that was removed after 
several days or weeks after surgery 13-15. Temporary stented reconstructions have 
disadvantages: because the stents are exteriorized they provide a greater risk for sperm leakage 
and infection; this could lead to sperm granuloma, antisperm antibody formation, vasitis and 
loss of patency from scar tissue formation.  
 
Absorbable intravasal stents 
In the early 1980s more studies were reported using absorbable material as an  
intravasal stent.  Redman 16 used an intraluminal stent of catgut in 20 patients and achieved an 
overall pregnancy rate of 65%; the successful group included three patients who had a  
vasectomy >10 years earlier. Montie et. al.17   reported a study in a dog model; one group had a 
conventional sutured vasovasostomy with 6/0 silk and another three groups were reconstructed 
with intraluminal stents using either 3/0 polyglycolic acid or 3/0  
chromic catgut, using different types of approximation sutures. The best results were with the 
chromic catgut stents, and 6/0 catgut sutures for the anastomosis. Silk sutures resulted in severe 
granuloma formation and should therefore be rejected as a suturing material.  
Absorbable hollow stents were created to simplify the procedure and reduce operating time; 
these created perfect alignment of the vas defrens ends, and after 2-4 weeks most stents were 
dissolved. Nuwayser et.al. 18 were amongst the first to develop such a stent; they used starch, 
collagen and polyester as stent materials. The best results were seen in the polyester group, 
with patency in all 19 samples and rapid absorption at 10-14 days. The histological assessment 
showed excellent healing at the anastomotic site, with the presence of normal epithelium and 
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no stricturing. There was plentiful sperm in the lumen, with normal sperm morphology. Flam 
et.al.1 used an absorbable hollow polyglycolic acid stent, and described advantages of ease of 
anastomosis, reduction of perivasal inflammation as a result of minimal extravasation of sperm, 
maintenance of luminal patency, and satisfactory approximation of the vas deferens ends after 
placing of the stent. Remarkably, they reported more perivasal inflammation at the anastomotic 
site of an unstented controle group. This sperm leakage and inflammatory reaction could 
increase the risk of late scarring. Hollow, biflanged, hydrolysable, self-retaining stents of 
polyglycolic acid were used by Berger et al. 19 in a randomized prospective comparative study 
between a stented and a modified two-layer vasovasostomy group in rats and dogs. The 
outcome suggested better patency rates in the stented group (80% vs 20%).  
By contrast Rothman et.al.20 in 1997 reported an extensive prospective randomized study  
comparing a microscopic two-layer vasovasostomy with an absorbable polyglycolic acid stent 
in 116 men who had a vasectomy reversal. In all, 64 men had a stented reconstruction and 52 
were repaired with a two-layer microscopic reconstruction. Paternity rates were significantly 
better in the unstented group. A bias in this study was the incomplete follow-up; in many cases 
only one semen sample was investigated per subject aftere surgery, and this undermines a well 
documented comparison of patency rate. Nevertheless, information (by letter, telephone or 
outpatients visits) on paternity was available for 95% of patients, showing significantly better 
results in the non-stented group (51 vs 22%).  
 
Non-absorbable stent 
Because of these conflicting results with absorbable hollow stents, we decided to assess the 
present stent, a permanent, non-absorbable inert polymeric stent made of biomaterials with a 
different configuration. We considered that the non-absorbable property of this stent and the 
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inertness of the material would provide a permanent open lumen of the vas deferens at the site 
of the anastomosis. By contrast with previously discussed animal studies, we decided to 
provide a longer follow-up with more frequent semenanalyses. In the present study there were 
no significant differences in the outcome of the total sperm count, motility  and PMSD between  
groups. The present study is the first to use a non-absorbable polymeric hollow stent, with 
results similar to the one-layer vasovasostomy technique. There was no late stricturing in the 
stented group; the benefit of this is stressed by Carbone et al. 21 and Belker 22, who described 
the adverse effect of partial obstruction on the final outcome of a vasectomy reversal. In 
humans, the procedure should be easy and can be done by a surgeon not necessarily skilled in 
microscopy. Further investigations will be conducted in men to support the present findings 
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Several factors influence the clinical result of a vasovasostomy, including surgical technique, 
antisperm-antibodies, long-term high intravasal and epididymal pressure after vasectomy, and 
the obstruction interval between the vasectomy and reversal 1-3. 
Moreover, complications can occur locally in the anastomosis area, such as the development 
of scar tissue and granuloma formation. These reactions are mostly due to traction and/or 
devascularization of the vas wall, eventually leading to sperm leakage which compromises the 
anastomosis 4. Several weeks to months after the reversal procedure, stricturing in the 
anastomosis area can develop, resulting in a partial or complete stenosis. Initial patency will 
be compromised due to this stricturing. Several studies indicate that a large proportion of 
vasovasostomy failures are the result of inadequate sperm passage and/or 
testicular/epididymal tissue damage. Most of the sperm in the ejaculate passes from the 
epididymis to the vesicles at the time of the intercourse 5. As a result, a poor anastomosis will 
have a deleterious effect on fertility 4,6. Because of this risk of obstruction, but also because of 
the time required for a microsurgical anastomosis, we started to develop a technique with a 
hollow non-absorbable polymeric stent. 
The use of this hydrophilic stent, with autodilating capacity, could theoretically help to 
prevent the secondary stricturing of the anastomosis area. It was assumed that narrowing of 
the anastomosis by fibrosis would be prevented because of the solid structure of the stent. 
Local sperm leakage could be prevented by the use of an intraluminal stent covering the 
anastomosis. A very important issue in favor of using a stent is proven inertness of the 
biomaterial stent, limiting inflammatory reaction in the vas wall that would probably impair 
patency. Because of the permanent position of the implanted stent, any intraluminal migration 




the stent was contructed with a central ridge to avoid migration. 
The aim of this study was to examine the histological consequences of a stented 
vasovasostomy at the site of the anastomosis. Because we performed an immediate 
reconstruction after transsection, we did not examine the effect of a prolonged obstruction on 
the tissue of testes and epididymi. We studied the testicular and epididymal tissues for 
possible tissue changes in those rabbits with partially or fully obstructed vas deferens at the 
time that they were sacrificed either in the stented group or in the conventional group. 
The microscopical reconstruction was performed using a single layer anastomosis so that 
operating time would be reduced considerably compared to a two-layer anastomosis.  The 
beneficial effect of a two-layer anastomosis over a one-layer anastomosis is still under 
discussion 7,8. Finally, the histologic results were correlated with the clinical semen outcomes. 
 
Materials and Methods 
We used a total of 30 New Zealand White rabbits for this study. All animal experiments were 
conducted according to the Principles of Laboratory Animals Care (prepared by the National 
Institutes of Health, NIH Pub. No. 85-23 rev. 1995). These rabbits (age ranging between 1/2 
to 1 year) were chosen because of their easily accessible vas deferens, situated in a stretched 
prepubic area. Proven patency was a condition for being admitted to this study. 
Two rabbits acted as normal controls and 28 rabbits were included in a randomized 
comparative study between the conventional microsurgical procedure and the vasovasostomy 
using the newly developed biocompatible hollow stent. During follow-up two rabbits died 
soon after the operation; one because of pneumonia and the other of a gastric hair ball. 






The stent itself consists of biocompatible material and has several physical characteristics to 
simplify the insertion into the vas. In the dry state the stent has certain stiffness and is 
conically shaped at both ends to facilitate the introduction. After 1 to 2 minutes it starts to 
absorb seminal en serous fluids. This initiates swelling of the stent which then becomes  more 
flexible. There is a transverse ridge in the middle part of the stent to prevent the stent from 
migrating from its original anastomosis area (fig 1). 
 






The stent was constructed of  n-vinylpyrrolidone, n-butylmethacrylate, and the bifunctional 
cross-linking agent tetraethyleneglycol dimethacrylate. These reactive substances were 
polymerized using 2,2’-azobisisobutyronitrile (AIBN) as the radical initiator. The stent thus 
comprises a hydrophilic and a hydrophobic component in a 2:3 molar ratio. The hydrophilic 
component of biocompatible material provides the rubbery characteristics of the material after 
insertion into the vas deferens. 
Ketamine 0.5 mL/kg and xylazine 0.5 mL/kg were injected IM to induce anaesthesia; 
anaesthesia was maintained by a mixture of ketamine/xylazine (2:1) 0.2 mL/30 min. IV 
throughout the operation. The rabbit was placed in a supine position and a transverse skin 
incision was made over both spermatic funiculi. The spermatic internal fascia was opened and 
the vas deferens, lying loose and next to the funiculus, was easily exposed leaving the scrotal 
contents in situ. The vas was cut transversally and reconstructed immediately. The animals 
were randomized either for bilateral microscopical reconstruction with 4 to 5 one-layer 
prolene 8-0 sutures or for placement of stents bilaterally. Both vas ends were approximated 
with three 8-0 prolene sutures overlying the stent. The vas was repositioned underneath the 
funiculus and the spermatic internal fascia and overlying skin were closed with 4.0 vicryl. 
During the postoperative period the animals obtained buprenorfin 0.1 mL/kg IM for a 
maximum of 48 hours. 
Semen for semen analysis was obtained 3-4 days before the operation. After the operation at 
least 4 to 5 semen samples were taken per animal with time intervals of 7-10 weeks. For 
collection of semen, an artificial vagina system was used, which is normally applied in 
agricultural artificial insemination stations for rabbits. Sperm parameters that were collected 






Histological examinations were performed on the rabbits, including the two normal rabbits 
that acted as normal controls. The autopsies were performed shortly after taking the final 
semen sample. Histological sections in the stented group were taken at an average of 41 
weeks (39-44) after the initial operation versus 42 weeks (40-47) in the conventional group. 
The vasa deferentia, the testes, and the epididymi were excised and fixed in neutral buffered 
4% formalin and paraffin embedded for further sectioning. Multiple tissue segments of each 
vas deferens were taken: one from the anastomosis area (stent or conventional) and four 
segments immediately proximal and distal to the anastomosis. Two to three samples were 
taken from the testes and epididymi for evaluation of histological changes after both 
procedures. All samples were cut at 4μm thickness, and slides were stained with 




Morphologic findings in stented rabbits: 
During excision of the anastomotic areas, for further histological examination, minimal 
adhesions of the anastomosis site were seen with its surrounding tissue. In one case there was 
a migration of the stent. The stent was found 2 cm more distally and proved to be patent.  
Microscopy showed that the stented rabbits all had patent vasa on either side of the implant, 
without any signs of complete or partial stenosis. After extensive examination two groups of 
stented animals could be distinguished (fig 2); 
 
• The first group of 11 stented rabbits showed a very similar histological pattern among 
all cases at the site of the stent. A minor subepithelial inflammatory reaction within the 




eosinophilic granulocytes, incidental macrophages, and in one case histiocytes. The 
mainly eosinophilic infiltrate did not appear to lead to destruction of the stent or 
invasion of the vas wall. The testes and epididymi appeared to be normal and all the 
transverse sections through the stent demonstrated patency. 
• The second group consisted of two rabbits. One had a major transmural histiocytic 
reaction to the stent and the other presented with severe eosinophilic infiltration 
involving the epithelium, resulting in epithelial destruction and atrophy. In both cases 




























Fig 2.  Hematoxylin & eosin stained sections through vas deferens of sten- reconstructed animals at the 
anastomosis area.  
 
A:  transverse section through normal vas deferens away from the stent area. 
B: stent lying adjacent to the vas wall with epithelial flattening and the presence of paraluminal eosinofylic 
reaction (arrow).  




Morphologic findings in the microscopically sutured rabbits: 
Surgical excision of the anastomosis area subjectively revealed more adhesions compared to 
the stent group. All the anastomoses were patent, as proven by the finding that all transverse 
sections of the vas distal to the anastomosis contained sperm cells. Remarkable was the fairly 






• The first group consisted of eight rabbits that presented with normal anastomotic site 
and normal vas diameters. Histologically, complete recovery of the epithelial layers 
was found without stricturing of the anastomosis. Except for one rabbit, who 
developed chronic epididymitis with lymphocytic infiltrates, all the testes and 
epididymi tissue segments appeared normal with no distension of the tubules 
compared to normal controls. The tubules were fully filled with sperm. 
• The second group of five rabbits presented with partial obstruction. Transmural 
infiltration of lymphocytes and histiocytes was seen, resulting in fibrotic reaction with 
collagen dispositions and stricturing. Severe foreign body reactions were seen at the 
site of the sutures. Despite these partial obstructions, the parenchyma of testes and 







































Fig 3. Various histologic sections of vas deferens and epididymis in conventional microscopically reconstructed 
animals using 8.0  prolene sutures. 
 
 A: normal anastomoses with no stricturing and complete recovery of epithelial layer; remnants of prolene 
sutures are seen (arrow). 
B: severe stenosis with paraluminal fibrotic reactions and intraluminal remnants of prolene sutures (arrows).  
C:  normal epididymis, tubules filled with spermcells.  



















Morphologic findings in relation to clinical outcome after vasovasostomy: 
All the vasa were patent in both the stent group and the conventional group. All the animals 
underwent a preoperative semenanalysis to prove their patency. The 26 animals treated, 
provided 141 semen specimens (26 presurgery and 115 postsurgery). The specimens were 
taken at regular intervals from 2 weeks to 47 weeks after surgery. Mean, median, minimum, 
maximum and standard deviation levels were measured for total sperm count, motility and 
progressive motile sperm density (PMSD) in both groups. Following surgery, there was a 
statistically significant difference between conventionally and stent-treated animals with 
respect to the total sperm count (p=0.050, linear regression analysis with random effects). The 
average total sperm count or concentration increased in both groups, but more so in the stent 
group. When calculating the average postsurgery motility per animal, we initially observed a 
decrease in motility which later on improved. Overall no statistical significant difference in 
motility between the conventionally and stent-treated animals was noted (p=0.11, non-linear 
regression with random effects). This same course was seen for the average PMSD 
concentrations, again showing no statistical differences between the two groups (p=0.71, non-





Influence of partial or total anastomotic obstruction after vasectomy reversal. 
Surgeons are aware of the fact that secondary stricturing of the anastomosis is detrimental for 
patency rates.  In searching Pubmed for this subject (1980-2004) only a limited number of 
articles are found discussing this problem. Carbone et al 4 described the role of partial 
obstruction causing infertility after vasovasostomy. It is a general believe that persistent 
infertility after vasectomy reversal is highly attributed to the presence of antisperm antibodies. 
In this study 20 patients obtained a vasectomy reversal, 14 of them were believed to have a 
partial obstruction based on mild to moderate epididymal fullness by palpation. All the 
patients had a significant binding of antisperm antibodies to the sperm surface. These 14 
patients underwent a repeat vasectomy reversal and revealed markedly improved semen 
motility (mean of 4.4% to a mean of 52.3%). Sperm concentration levels increased from 17.1 
to 35.8x106/ml. The overall antisperm antibodies binding did not change after re-
vasovasostomy. These results led to the conclusion that the poor sperm quality after the first 
vasectomy reversal was mainly the result of partial obstruction and not the mere presence of 
antisperm antibodies. Royle and Hendry 9 explored the scrota of 32 men who had a failed 
vasectomy reversal resulting in azoospermia or extreme oligozoospermia. Of 23 men who had 
azoospermia 12 patients had a completely blocked anastomosis. After repeat vasovasostomy 
normal sperm counts were produced in 10 of the 12 patients. 
The importance of total or partial obstruction after vasectomy reversal was also highlighted in 
several other studies. The main message of all these studies was that microsurgical vas 
reconstruction following failed vasectomy reversal, due to total or partial obstruction, is 
associated with high patency and pregnancy rate at short-term follow-up 10-13. 
 




rates. Therefore it is of extreme importance that the first reconstruction is technically 
successful.  Stricturation of the anastomosis is very often technically difficult to repair 
frequently forcing a surgeon to perform vasoepididymostomy with less favorable results. 
 
Biodegradable stents versus suture ligatures. 
In the literature stents used for vasovasostomy are all biodegradable. The reason for most 
authors for using such a stent was that a perfect alignment of the vas ends was obtained and 
possible leakage was prevented. Several studies tried to prove that intraluminal stenting 
showed less stricturation than sutured anastomosis. Flamm et al. 14 presented a study using 
polyglycolic acid stents in the reconstruction of vas deferens in rats. One side underwent a 
microscopic conventional sutured reconstruction with interrupted 10-0 Dermalon, and 
continuity of the collateral vas was restored with an absorbable polyglycolic acid stent. After 
6 weeks the stent was degraded and just a slight mucosal inflammation was left. Narrowing of 
the anastomoses occurred in both groups but was more present in the non-stented group in 
combination with more perivasal inflammation and late cicatrization, probably due to 
extravasation of sperm. Flamm et al. pointed out that prevention of sperm leakage at the site 
of the anastomosis was of importance in preventing secondary stricturing. 
Montie et al. 15 also used absorbable material as an intravasal stent. They described the 
histological effects in dogs in the wall of the vas deferens at the site of the anastomosis. They 
compared a conventional sutured vasovasostomy (6-0 silk) with intraluminal stents using 
either 3-0 Dexon (polyglycolic acid synthetic absorbable stent) or 3-0 chromic catgut using 
different types of approximation sutures. In the silk group, severe granuloma formation and 
local inflammatory reactions were seen. Minimal intraluminal tissue reaction in the vas wall 
was seen after reconstruction with an intravasal chromic catgut stent as well as with chromic 




Nuwayser et.al. 16 experimented with different materials. They used starch, collagen and 
polyester as a stent in an animal study. Polyester biodegradable stents demonstrated the best 
results with 100% patency and rapid absorption within 10-14 days. The anastomosis site 
showed excellent healing with normal vas epithelium and no stricturation. Finally Berger et 
al. 17 presented a stent study in rats and dogs using a polyglycolic acid absorbable stent. They 
compared a stented vasovasostomy group with a modified two-layer technique. Scanning 
electron microscopy showed superior re-epithelialization and normalization of morphology in 
the stented group. 
In all the above-mentioned studies superior healing of the anastomosis was seen with stents 
compared to suture ligatures. 
 
Why a non-absorbable polymeric stent? 
Histological alterations of the vas anastomosis were observed in our study. Especially 
borderline inflammatory reactions of the vas were seen in the stent group with a subepithelial 
eosinofilic and histiocytic reaction. In the conventional microsurgical sutured group, more 
partial obstructions due to severe fibrotic changes in the anastomotic area were noted. The 
idea of developing a nonabsorbable stent was born from the concept that stricturing at the site 
of the microsurgical sutured anastomosis was caused by sperm leakage owing to lack of water 
tightness, eventually leading to sperm granuloma development and cicatrization. This leakage 
could possibly be prevented by a permanent stent in situ covering the anastomosis.  
Our study is the first to investigate a nonabsorbable polymeric stent in the reconstruction of 
the vas deferens. Despite the fact that slight inflammatory reactions in the vas wall of the 
stented group were observed, we assume that these minor reactions are less relevant than the 
fibrotic stricturations occurring from the conventional microscopic one or two layer 




With the dissolving of these absorbable stents the anastomosis area is exposed within several 
weeks. It is our believe that even after the absorption of the stent the anastomosis area is still 
at risk of stricturation owing to the fact that the anastomosis area is still biologically active or 
that the inflammatory respons to resolve the stent, could cause secondary stricturing of the 
anastomosis. The permanent position of a nonabsorbable biocompatible polymeric stent at the 
site of the anastomosis could prevent any danger of secondary stricturation and thus provide 
persistent patency. The development of inert biocompatible materials justifies the 
consideration of permanent stent implants. Therefore we will continue to investigate this stent 
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Chapter 1  
Objective: To give an overview of the different vasectomy techniques utilized and try to 
explore from the literature what method of vasectomy could give the lowest risk of early 
recanalization. What is the exact definition of early recanalization. Should persistent non-
motile spermatozoa after vasectomy primarily be considered as early recanalization or as a 
succesful vasectomy outcome? In this review we also try to provide answers to this problem.  
Results: The no-scalpel technique has, besides lower complication rates, no advantages 
compared to the conventional technique. Simple ligatures of the vasal ends provide, due to 
sloughing, the highest chance of recanalization (1-5%). Cautery of a vasal segment over a 
length of more than 1 cm and interposition of fascial sheath, together with the technique of 
folding back of vasal ends, brings the best results. Resection of long segments is probably not 
necessary to improve results. Resection of long segments provides more complications and 
reduces the opportunities of vasectomy reversal. Percutaneous vasectomies using silicone plugs 
should be rejected.  
Leaving the testicular side open at the time of vasectomy could be advantageous. Open ended 
vasectomies could be of benefit when considering future vasectomy reversal. Sperm granuloma 
development at the testicular-end in open vasectomies has the advantage of preventing 
irreversible damage to the testis, improving the chances of successful reversal. The sperm 
granuloma development could act as pressures relieve valve also reducing postvasectomy 
epididymal congestive pain. 
Besides two consecutive samples of azoospermia, persistent non-motile sperm (<10.000/ml) 
should also be considered as a criterion for success. Early recanalization is defined as 
persistence of motile sperm four months after vasectomy. 
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Conclusion(s): Well designed randomized trials have to be conducted to prove that open-ended 
vasectomy, without resection of long segments and cautery of the abdominal end over at least 1 
cm in combination with fascial interposition, is probably the method of choice in an era where 
the incidence of divorces are high and the chances of a restored child wish with a new partner is 
considerable. Persistent non-motile sperm (<10.000/mL) seven months after vasectomy should 
be defined as a successful outcome and not as early recanalization.  
 
Chapter 2 
Introduction: We determined the percentage of patients with nonmotile sperm 12 weeks after 
vasectomy and estimated the time needed for eventual azoospermia in these patients. We also 
recorded the percentage of patients with recurrence of nonmotile sperm after initial 
azoospermia post-vasectomy. 
Materials & Methods: A review was done of the semen analysis of vasectomies performed in a 
2-year period. Vasectomies were performed in an outpatient department of the University 
Hospital of Maastricht. Semenanalysis were performed in a group of volunteers from 4 months 
until 24 months after vasectomy. Amount and motility of sperm in postvasectomy semen 
samples were recorded. All the men were referred by the general practitioner for vasectomy.  
Results: Nonmotile sperm was found in 33% of the patients 12 weeks after vasectomy. The 
mean time to azoospermia was 6.36 months. Nonmotile sperm after initial azoospermia was 
found in 5 of 65 patients. 
Conclusions: Azoospermia as a criterion for sterility leads to unnecessary prolonged semen 
analysis in a large percentage of the vasectomized patients. Reappearance of nonmotile sperm 





This review chapter starts with a description of the microscopical vaovasostomy technique. The 
role of optical loupes versus microscopes is discussed. Details of the microscope like length of 
binocular tubes, power of the eyepiece and the power of the magnification changer are 
reviewed. Optimal care has to be taken for the exact positioning of the microscope because non 
optimal visualization can be of bother during the entire operation. The use of high quality 
surgical instruments is of utmost importance for a successful vasovasostomy. Various 




Introduction: In this series we present the results of a retrospective analysis of 66 vasovasos-
tomy procedures performed between 1983 and 1991.  
Materials & Methods: Obstructive intervals and serum antisperm antibodies were correlated 
with pregnancy and patency rates.  
Results: With obstructive intervals of less than 5 years a patency rate of 100% (31/31) was 
obtained. Even more than 10 years after reversal, pregnancy occurred in 25% (2/8) of the 
patients. Preoperative serum antisperm antibodies were correlated with pregnancy rates. 
Patients with a high agglutinin titre of 1/64 obtained a pregnancy rate of 23% (3/13). Those 
men who had no circulating antisperm antibodies in their blood had a significantly better 
chance in obtaining pregnancy (pregnancy rate 80%). In this study we accounted for an overall 
pregnancy rate of 51.5% (34/66) versus an overall patency rate of 84.8% (56/66).  
Conclusion: Neither long obstructive intervals nor high antisperm antibody titres should 
dissuade a surgeon from performing a vasovasostomy procedure 
 
 137
Chapter 5  
Objective: In this review article we want to investigate the current opinions regarding the 
influence of post vasectomy sperm granuloma, antisperm antibodies development and 
subsequent epididymal and/or testicular tissue changes on vasovasostomy results.  
Methods: literature search was performed using MEDLINE database on factors influencing 
outcome of vasectomy reversal. 
Results: Sperm granulomas occur in 10-30% of men who underwent a vasectomy. These sperm 
granulomas develop mainly at the epididymal area. Increased epididymal pressure leads to 
tubular ruptures causing fibrosis of the epididymal ductules and possible obstruction. Rupturing 
of these epididymal tubules is the probable cause of antisperm antibodies formation. 
Depositions of these humoral immune complexes in the epididymis and/or testis area have a 
complementary negative effect on these tissues. Open-ended vasectomies could have a 
beneficial effect on the prevention of granuloma formation at the epididymal area. Granuloma 
formation at the testicular open vasectomy end will eventually lead to reduced pressures in the 
epididymis, preventing further damage. Despite these advantageous aspects of open-ended 
vasectomy no scientific study has proven up to now that better vasovasostomy results are 
obtained with this open-ended technique. Human and animal studies suggest that vasectomy 
causes changes in interstitial tissues of the epididymis with much more densely occupied fibers. 
Testis tissue is less frequently damaged due to obstruction than the epididymis region. Probably 
a lot of pressure is already released at the epididymal area as described previously. If changes 
in the testis occur, it results in increased seminiferous wall thickness, focal interstitial fibrosis 
and changes in the interstitial area. It is unclear whether these changes are reversible after 
vasovasostomy? From animal studies we know that progression of these changes are probably 
reduced but not reversed. Animals with smaller testicles after vasectomy showed more severe 
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changes of the seminiferous tubules and higher levels of antisperm antibodies were measured. 
The effects of tissue damage to the epididymis and testis on vasovasostomy results in men 
remains still unclear. Literature on this subject is rare and describes small series. Although it 
seems obvious, until now no well designed study is performed to verify whether these tissue 
alterations have a detrimental effect on semen quality after vasectomy reversal. 
Conclusion:  Open-ended vasectomies could have a beneficial effect on the prevention of 
epididymal and testicular tissue changes, granuloma formation and antisperm-antibodies 
production. Despite these advantageous aspects of open-ended vasectomy no scientific study 




Introduction: Vasectomy has become popular since it is the safest surgical method for 
contraception. It is known that approximately 6 % of the men that undergo vasectomy will seek 
reversal (vasovasostomy). This operation is, however, technically demanding and relatively 
time-consuming. This study was based on the hypothesis that a polymeric mini-stent can 
facilitate and accelerate vasovasostomies.  
Materials&Methods: A mini-stent was manufactured out of a cross linked hydrogel 
biomaterial, which was synthesized from N-vinyl-pyrrolidinone (NVP), n-butylmethacrylate, 
and (triethyleneglycol) dimethacrylate. The device was tested in 28 rabbits, which were divided 
over two equal groups. In one group, the vasa deferentia were dissected and reanastomosed via 
microsurgical one-layer technique (end-to-end group). In the other group, the vasa deferentia 




Results: Sperm counts revealed 100 % patency in both groups, i.e. all vasovasostomies were 
successful. It was experienced that the operation was easier and faster in the case of the mini-
stent, probably since the mini-stent keeps the lumens of both vas ends exactly in line during 
suturing.  
Conclusion: This study demonstrates the feasibility of the mini-stent. Further work is necessary 
to evaluate the utility of this approach for clinical vasovasostomies.  
 
Chapter 7 
Objective(s): To investigate the use of a newly designed stent in the reconstruction of the vas 
deferens 
Materials and Methods: In 26 New Zealand White rabbits, 13 conventional one-
layermicroscopic reconstructions were compared with 13 stebted recomstructions of the vas 
defrens.The newly designed nonabsorbable polymeric stent was shaped to facilitate the 
rejoining of the two loose ends of the vas deferens, using a central ridge to prevent migration.  
Semen was collected before and after surgery, using an artificial vaginal system  
(26 samples before and 115 samples after surgery). The individual and average total sperm 
count, motility and progressive motile sperm density (PMSD) were compared after surgery for 
both groups. After the final semen analysis, rabbits were killed and patency was assessed 
histologically at the site of the anastomosis.  
Results: After an initial decline, the mean total sperm count increased in both groups. The 
increase was significantly larger (p=0.05) in the stented rabbits. The mean motility and PMSD 
showed no significant differences between both groups (p=0.11 and 0.71 respectively).  
Histological examination of the anastomosed area showed partial obstruction (>50% narrowing 
of the original lumen) in five of the 13 conventionally treated rabbits, with no strictures in the 
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stented group. Despite the narrowing in the conventional group the patency rates were not 
affected. The mean (range) operating time for the conventional and stented groups was 132 
(99-168) and 98 (62-113) min, respectively (p<0.001)  
Conclusion: The total sperm counts, motility and PMSD showed no or little difference after 
surgery between the conventional and stented rabbits. The stented reconstruction was easy, had 
no secondary stricturing and reduced the operating time. 
 
Chapter 8 
Objective: To investigate whether a newly designed non absorbable polymeric stent for the 
reconstruction of the vas deferens provided less stricturing at the site of the anastomosis  in 
comparison with the conventional microsurgical  reconstruction of the vas deferens. 
Design: Prospective randomized study in 26 rabbits, comparing the one-layer microscopical 
sutured procedure with a biocompatible stent. 
Setting: University animal laboratory center 
Interventions: Pre- and postoperative average total sperm count, motility and progressive 
motile sperm density levels (PMSD) were measured. Histological sections were taken from the 
area of the anastomosis, testes and epididymi after final semen analysis. 
Main outcome measures: Rates of stricture and semen parameters 
Results: The vas deferens of the rabbits that received a stent, showed an inflammatory reaction 
within the vas wall, adjacent to the stent. Transmural histiocytic or eosinophilic reactions were 
seen in 2/13 (15%) of the stented animals, with atrophy of the epithelium. Histological cross-
sections of the stented vas deferens demonstrated patency. Microscopically sutured rabbits 
showed more partial obstructions at the site of the anastomosis 5/13 (38%) with transmural 
infiltration of lymphocytes and histiocytes. Despite these partial obstructions the vasa were 
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patent. There was a statistically significant difference in favor of the stent with respect to the 
total sperm count (p=0.05). No differences were seen in motility (p=0.057) or PMSD’s 
(p=0.13). 
Conclusions: The newly developed stent provided patency rates comparable with the 












Inleiding: In dit overzichtsartikel geven we een beschouwing van de diverse vasectomie 
technieken en daarnaast proberen we aan de hand van literatuurgegevens aan te geven welke 
vasectomie vorm het laagste risico heeft op vroege rekanalisatie. Wat is de precieze definitie 
van vroege rekanalisatie? Moeten persisterende non-motiele zaadcellen na vasectomie geduid 
worden als vroege rekanalisatie of als een geslaagde vasectomie. In dit overzichtsartikel 
proberen we ook op die vraag een antwoord te geven.  
Resultaten: De niet-scalpel techniek heeft, behoudens lagere complicatie kansen, geen evidente 
voordelen boven de conventionele  techniek. Eenvoudige onderbinding van de vasa deferentiae 
uiteinden leidt tot necrotiseren van deze uiteinden en geeft het grootste risico op rekanalisatie 
(1-5%). Coaguleren van een vas uiteinde over een lengte van meer dan 1cm en interpositie van 
weefsel tussen deze uiteinden in combinatie met omklappen van de vasa, geeft het geringste 
risico op rekanalisatie. Excisie van een lang vas segment is niet nodig en levert geen voordelen 
op. Het verwijderen van lange vas deferens stukken tijdens de vasectomie geeft uiteindelijk 
meer complicaties en verkleind de mogelijkheid op een eventuele vas deferens reconstructie. 
Het gebruik van silicone plugs om een vasectomie te doen moet worden afgeraden. Het open 
laten van het testiculaire vas deferens uiteinde ten tijde van de vasectomie zou mogelijk 
voordelen kunnen opleveren. De zogenaamde ‘open-ended’ vasectomie zou het voordeel 
hebben dat de kans op een succesvolle vasovasostomie wordt verruimd. Aan het testiculaire vas 
uiteinde kan zich een spermagranuloom ontwikkelen welke op zijn beurt weer als een 
decompressieklep kan fungeren. Het voordeel is dat onomkeerbare beschadigingen aan testis en 
epididymis zouden kunnen worden voorkomen waardoor er een verbeterde kans ontstaat op een 
succesvolle vas deferens reconstructie. Bijkomend voordeel van deze decompressie techniek is, 
dat er minder post-vasectomie stuwingspijnen van de epididymis worden beschreven. 
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Behoudens twee opeenvolgende spermacontroles met azoospermie is de aanwezigheid van 
persisterende non-motiele zaadcellen (<10.000/ml) ook een criterium voor een successvole 
vasectomie. Vroege rekanalisatie wordt gedefinieerd als persisterende motiele zaadcellen vier 
maanden na een vasectomie. 
Conclusie: Goed opgezette gerandomiseerde trials zijn nodig om aan te tonen dat ‘open-ended’ 
vasectomie zonder verwijdering van grote delen vas, in combinatie met coagulatie van het 
abdominale vas uiteinde over een lengte van 1cm en weefsel interpositie en omklappen, de 
methode is die mogelijk de voorkeur heeft. Deze methode is vooral van belang gezien de 
toename van het aantal echtscheidingen met nadien herstel van kinderwens. Persisterende non-
motile zaadcellen (<10.000/ml) zeven maanden na vasectomie kunnen beschouwd worden als 
een succesvolle vasectomie en niet als vroege rekanalisatie.  
 
Hoofdstuk 2 
Inleiding: In dit onderzoek werd het percentage patienten bepaald met non-motile spermatozoa 
12 weken na vasectomie en tevens werd gekeken naar de tijd die nodig was bij deze patienten 
om uiteindelijk een vasectomie te bereiken. Daarnaast hebben we een registratie verricht van 
het aantal patienten dat een terugkomst heeft ontwikkeld van non-motiele spermatozoa nadat 
bij deze patienten aanvankelijk een azoospermie werd vastgesteld. 
Materialen en methoden: Er werd een overzicht verricht van zaadanalyses bij vasectomie 
patienten over een periode van twee jaar. De vasectomies werden poliklinisch verricht aan de 
afdeling urologie van het Academisch Ziekenhuis te Maastricht. Semenanalyses werden 
verricht in een groep vrijwilligers vanaf 4 tot 24 maanden na de vasectomie. Onderzocht 
werden de concentratie van het aantal spermatozoa en de motiliteit. Alle patienten werden via 
de huisarts verwezen voor een vasectomie.  
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Resultaten: De aanwezigheid van non-motiele spermatozoa werd bij 33% van de patienten 12 
weken na de vasectomie nog vastgesteld. Azoospermie werd uiteindelijk bereikt gemiddeld 
6.36 maanden na de vasectomie. De terugkomst van non-motiele zaadcellen na aanvankelijke 
azoospermie werd bij 5 van de 65 patienten vastgesteld. 
Conclusie: Azoospermie als absoluut criterium voor steriliteit na vasectomie leidt tot onnodig 
langdurige zaadcontroles bij een groot percentage van de vasectomie patienten. Terugkomst 
van non-motiele zaadcellen werd vastgesteld in een onverwacht groot aantal patienten.  
 
Hoofdstuk 3 
Dit overzichtsartikel handelt over de microchirurgische verrichte vasovasostomie. De rol van 
van een loup-bril versus de operatie microscoop wordt bediscussieerd. Details van de 
microscoop waaronder oculairen, vergrotingsfactor en scherptediepte worden gedetaileerd 
beschreven. Belangrijk is dat de microscoop ten tijde van de vasovasostomie optimaal voor de 
chirurg wordt gepositioneerd. Insufficiente positionering leidt tot suboptimale visus en is 
gedurende de gehele ingreep tot last. Het gebruik van hoogwaardige microchirurgische 
instrumenten is absoluut noodezakelijk. De verschillende microchirurgische instrumenten 
worden beschreven en hun mechanische eigenschappen evenals hun functies worden belicht. 
 
Hoofdstuk 4 
Inleiding: In deze studie presenteren we de resultaten van een retrospectieve analyse van 66 
vasovasostomie operaties welke verricht werden tussen 1983 en 1991. 
Materialen en Methoden: Obstructie intervallen (periode tussen vasectomie en herstel) en 




Resultaten: Bij obstructie intervallen korter dan 5 jaren werd een doorgangkelijkheids 
percentage gemeten van 100% (31/31) in deze studie. Zelfs bij obstructieintervallen van meer 
dan 10 jaar werd nog een zwangerschapspercentage van 25% vastgesteld (2/8). Preoperatief 
bepaalde antisperma antilichamen werden gecorreleerd aan de zwangerschapspercentages. Die 
mannen die preoperatief geen antisperma antilichamen in hun bloed hadden, hadden een 
aanmerkelijk hogere kans op het verkrijgen van een zwangerschap (80%). In deze studie werd 
een overall zwangerschapspercentage vastgesteld van 51.5% (34/66) en een 
doorgankelijkheidspercentage van 84,8% (56/66). 
Conclusie: Langdurige obstructie intervallen of hoge antisperma antilichamen titers zouden een 
chirurg er niet van moeten weerhouden om een vasovasostomie te verrichten.  
 
Hoofdstuk 5 
Inleiding: In dit overzichtsartikel hebben we gekeken naar de actuele opinies over de invloeden 
van postvasectomie spermagranulomen en antisperma-antilichaam vorming op de resultaten 
van een vasosvasotomie. Zowel spermagranulomen als antisperma antilichamen hebben een 
schadelijke invloed op de epididymis en testis. Heeft schade toegebracht aan de epididymis of 
testis, ten gevolge van de vasectomie eveneens invloed op het resultaat van een 
vasovasostomie?  
Resultaten: Sperma granulomen komen voor bij 10-30% van de mannen die een vasectomie 
hebben ondergaan. Deze sperma granulomen komen vooral voor op epididymis niveau. 
Verhoogde drukken in de epididymis leiden tot rupturering van de tubuli waardoor fibrosering 
ontstaat van de ductuli met als gevolge verder obstructie. Rupturering van deze epididymale 
tubuli is zeer waarschijnlijk de oorzaak van het ontstaan van antisperma-antilichamen. Het 
neerslaan van deze immune complexen in de epididymis en/of testis hebben een additioneel 
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negatief effect op deze weefsels. Open-ended vasectomie (het openlaten van het testiculaire 
uiteinde ten tijde van de vasectomie) zou mogelijk een gunstig effect kunnen hebben op het 
voorkomen van deze epididymale granulomen. Granuloom vorming aan het testiculaire 
uiteinde kan leiden tot afname van druk in de epididymis doordat deze als een uitlaatklep 
fungeert als de druk te hoog wordt. Hierdoor kan verdere schade aan de epididymis voorkomen 
worden. Ondanks deze mogelijke voordelen van een open-end vasectomie is er tot op heden 
nog nooit een goede wetenschappelijke studie verricht waarbij onomstotelijk is komen vast te 
staan dat er betere vasovasostomie resultaten worden bereikt met deze techniek. Zowel studies 
in de mens als in dier tonen aan dat een vasectomie weefsel verandering geeft in interstitieel 
weefsel van de epididymis met een toenemende weefseldichtheid. Testis weefsel is minder 
vaak aangedaan door obstructie dan epididymaal weefsel. Mogelijk dat al veel overdruk via de 
epididymis wegstroomt ten gevolge van rupturering aldaar. Indien er door de druk toch weefsel 
veranderingen optreden in de testis dan zijn dat vooral verdikkingen in de wand van de tubuli 
seminiferi en locale interstitiele fibrose. Zijn deze weefsel veranderingen omkeerbaar na een 
vasovasostomie? Dieren studies hebben aangetoond dat verder progressie van deze afwijkingen 
wordt afgeremd echter de veranderingen die al zijn opgetreden zijn niet meer om te keren. 
Dieren met kleinere testikels enige tijd na vasectomie hebben ernstigere afwijkingen in hun 
tubuli seminiferi dan beesten met normale testikels na vasectomie. Ook hebben beesten met 
kleinere testikels een aanmerkelijke hogere concentratie van antisperma antilichamen. Het 
effect van weefsel beschadiging aan de testis en epididymis op vasovasosotmie resultaten is 
nog altijd onduidelijk. Literatuur over dit onderwerp is bijzonder schaars en beschrijft kleine 
series. Hoewel het voor de hand lijkt te liggen is er echter tot op heden geen enkele goed 
opgezette studie voor handen die bewijst dat deze weefsel veranderingen een negatieve invloed 
hebben op de zaadkwaliteit na vasovasostomie. 
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Conclusie: Open-end vasectomien kunnen mogelijk een gunstig effect hebben op het 
voorkomen van weefselbeschadigingen aan testis en epididydmis, granuloom vorming en 
antisperma-antilichaam vorming. Ondanks deze voordelige effecten van een open-end 
vasectomie is er tot op heden nog nooit een studie geweest die heeft aangetoond dat er betere 
vasovasosotmie resultaten worden verkregen met een open-end vasectomie. 
  
Hoofdstuk 6 
Inleiding:  Vasectomie heeft vooral aan populariteit gewonnen doordat de vasectomie een 
veilige en betrouwbare vorm van anticonceptie bleek te zijn. Het is bekend dat circa 6% van de 
mannen die een vasectomie hebben ondergaan dit ongedaan willen laten maken 
(vasovasostomie). Deze procedure is een tijdrovende technisch hoogstaande behandeling. De 
hypothese achter deze studie was dat een polymeren mini-stent de ingreep eenvoudiger zou 
maken en daardoor minder tijdrovend. 
Materialen en methoden: De mini-stent werd gemaakt van cross-linked hydrogel biomateriaal 
wat gemaakt was van N-vinyl-pyrrolidinone (NVP), n-butylmethacrylate en (triethyleneglycol) 
dimethacrylate. Deze stent werd getest op 28 konijnen welke verdeeld werden over twee 
groepen. In de ene groep werden de vasa deferentiae transversaal gekliefd en 
gereanastomoseerd met een microscopische one-layer anastomose (end-to-end groep). In de 
andere groep werden eveneens de vasa deferentia dwars gekliefd en deze werden 
gereconstrueerd met behulp van de implantatie van deze mini-stent.  
Resultaten: Zaadanalysen toonden aan dat er 100% doorgankelijkheid (patency) werd bereikt in 
beide groepen m.a.w. alle vasovasostomien waren succesvol. Het bleek dat de anastomose 
makkelijker en sneller te creëren was in de mini-stent groep doordat na plaatsing van de stent, 
het vas uiteinde perfect in een lijn lagen gedurende het hechten. 
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Conclusie:  Deze studie laat zien dat deze mini-stent geschikt lijkt voor het uitvoeren van een 
vasovasostomie. Toekomstige studies in de mens zullen de haalbaarheid van een dergelijke 
stent in een klinische situatie moeten aantonen. 
 
Hoofdstuk 7 
Inleiding: Doel van de studie was om de effectiviteit van een volledig nieuw ontworpen niet-
resorbeerbare polymere stent te onderzoeken voor de reconstructie van een zaadleider. 
Materialen en methoden: Uiteindelijk konden er 26 konijnen gebruikt worden voor een 
vergelijkende studie waarbij er 13 conventionele microscopische reconstructies werden 
vergeleken met 13 stent reconstructies. Een specifieke stentvorm van dit hydrofiele 
biocompatibele materiaal werd ontwikkeld om beide vas uiteinden makkelijker naar elkaar toe 
te brengen. Een centrale richel werd gecreëerd om migratie van de stent te voorkomen. Semen 
analyses werden gedaan zowel voor als na de operatie waarbij een kunstvagina werd gebruikt 
om het zaad op te vangen. ( 26 semen analyses voor en 115 na de ingreep). Postoperatief 
werden alle individuele en gemiddelde sperma concentraties (mil/ml) als wel 
motiliteitspecentages(%) en PMSD’s (progressieve motiele sperma dichtheid) vergeleken in 
beide groepen. Niet lang na de laatste zaadanalyse werden de konijnen geofferd en werd de 
doorgankelijkheid tevens histologisch onderzocht ter plaatse van de anastomose.  
Resultaten:  Nadat aanvankelijk de gemiddelde sperma concentraties kort na de ingreep 
daalden zagen we uiteindelijk een toename van de deze gemiddelde sperma concentraties in 
beide groepen. De toename van de gemiddelde sperma concentraties was statistisch significant 
beter in de stent groep (p=0.05). De gemiddelde motiliteit en PMSD toonden geen statistisch 
significant verschil in beide groepen (motiliteit p=0.11 en PMSD p=0.71). Histologisch 
onderzoek toonde aan dat er meer gedeeltelijke obstructie (>50% vernauwing van het lumen) 
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werd gezien in de conventionele microscopische groep (38%) versus géén vernauwing in de 
stent groep. Ondanks de grotere aantallen vernauwingen in de conventionele groep werden er 
geen verschillen in doorgankelijkheid aangetoond.  De gemiddelde operatieduur in de stent 
groep van 98 min (62-113 min) was significant (p<0.001) korter dan die van de conventionele 
groep 132min(99-168). 
Conclusie:  De postoperatieve sperma concentraties, motiliteitspercentages en PMSD’s toonden 
weinig tot geen verschillen aan tussen beide groepen. De stent reconstructies waren 
makkelijker uitvoerbaar, minder tijdrovend en toonden geen secundaire vernauwingen aan ter 




Inleiding: Om te onderzoeken of een nieuw ontworpen niet resorbeerbare polymeren stent voor 
het herstel van de zaadleider, minder vernauwingen gaf ter plaatse van de anastomose 
vergeleken met de conventionele microscopische reconstructie. Het betrof een prospectieve  
gerandomiseerde studie in 26 konijnen waarbij een éénlagige microscopische reconstructie 
werd vergeleken met een reconstructie waarbij gebruik werd gemaakt van een niet-
resorbeerbare biocompatibele polymeren stent. 
Materialen en methoden: Pre en postoperatieve gemiddelde sperma concentraties, motiliteit en 
progressieve motiele sperma concentraties (PMSD) werden bepaald. Histologisch onderzoek 
werd verricht van de anastomose, epididymis en testis kort nadat de laatste semencontrole heeft 
plaatsgevonden. 
Resultaten: De vasa deferentiae van konijnen die eens stent kregen  toonden een 
ontstekingreactie in de wand van het vas deferens daar waar de stent tegen het epitheel van het 
vas deferens lumen was gelegen. Transmurale histiocytaire of eosinofiele reacties in combinatie 
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met atrofie van het epitheel werden gezien in 2/13 (15%) konijnen die een stent hadden 
gekregen. Histologisch onderzoek van transverse coupes van het vas deferens toonden 
doorgankelijkheid aan. Konijnen die microscopisch werden gereconstrueerd toonden meer 
partiele obstructies aan op de plaats van de anastomose 5/13 (38%) vergeleken met 
conventionele microscopische reconstructies. Tevens werd ter plekke transmurale infiltratie van 
lymfocyten en histiocyten gezien. Ondanks deze gedeeltelijke vernauwingen waren de vasa 
deferentiae toch goed doorgankelijk. Er bleek een statisch significant voordeel te zijn voor de 
stent groep als het ging om de sperma concentraties (p=0.050) . Geen verschillen werden 
gezien in motiliteit (p=0.057) of PMSD (p=0.13). 
Conclusie: De nieuw ontwikkelde stent gaf vergelijkbare doorgankelijkheid vergeleken met de 
conventionele microscopische reconstructie maar toonde aanmerkelijk minder secundaire 
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